BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eng C. PTEN: One Gene, Many Syndromes. Hum Mutat 2003;22:183-98. [DOI: 10.1002/humu.10257] [Cited by in Crossref: 587] [Cited by in F6Publishing: 502] [Article Influence: 32.6] [Reference Citation Analysis]
Number Citing Articles
1 Nosé V. Familial thyroid cancer: a review. Mod Pathol 2011;24:S19-33. [DOI: 10.1038/modpathol.2010.147] [Cited by in Crossref: 99] [Cited by in F6Publishing: 56] [Article Influence: 9.9] [Reference Citation Analysis]
2 Allain DC. Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology. J Mol Diagn. 2008;10:383-395. [PMID: 18687797 DOI: 10.2353/jmoldx.2008.070161] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
3 Zhou L, Luo L, Hui X, You C, Yang Y, Xu J. Three adolescents with Lhermitte-Duclos disease. Journal of Clinical Neuroscience 2009;16:124-7. [DOI: 10.1016/j.jocn.2008.02.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
4 Walker CL, Xu XM. PTEN inhibitor bisperoxovanadium protects oligodendrocytes and myelin and prevents neuronal atrophy in adult rats following cervical hemicontusive spinal cord injury. Neurosci Lett 2014;573:64-8. [PMID: 24582904 DOI: 10.1016/j.neulet.2014.02.039] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
5 Shaco-Levy R, Jasperson KW, Martin K, Samadder NJ, Burt RW, Ying J, Bronner MP. Gastrointestinal Polyposis in Cowden Syndrome. J Clin Gastroenterol 2017;51:e60-7. [PMID: 27661969 DOI: 10.1097/MCG.0000000000000703] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 6.7] [Reference Citation Analysis]
6 Pezzolesi MG, Platzer P, Waite KA, Eng C. Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome. Am J Hum Genet. 2008;82:1141-1149. [PMID: 18460397 DOI: 10.1016/j.ajhg.2008.04.005] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 5.5] [Reference Citation Analysis]
7 Crowder RJ, Lombardi DP, Ellis MJ. Successful targeting of ErbB2 receptors-is PTEN the key? Cancer Cell. 2004;6:103-104. [PMID: 15324690 DOI: 10.1016/j.ccr.2004.08.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
8 Kang X, Song C, Du X, Zhang C, Liu Y, Liang L, He J, Lamb K, Shen WH, Yin Y. PTEN stabilizes TOP2A and regulates the DNA decatenation. Sci Rep 2015;5:17873. [PMID: 26657567 DOI: 10.1038/srep17873] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
9 Chai AP, Chen XF, Xu XS, Zhang N, Li M, Li JN, Zhang L, Zhang D, Zhang X, Mao RR, Ding YQ, Xu L, Zhou QX. A Temporal Activity of CA1 Neurons Underlying Short-Term Memory for Social Recognition Altered in PTEN Mouse Models of Autism Spectrum Disorder. Front Cell Neurosci 2021;15:699315. [PMID: 34335191 DOI: 10.3389/fncel.2021.699315] [Reference Citation Analysis]
10 Milam MR, Celestino J, Wu W, Broaddus RR, Schmeler KM, Slomovitz BM, Soliman PT, Gershenson DM, Wang H, Ellenson LH, Lu KH. Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine model. Am J Obstet Gynecol 2007;196:247.e1-5. [PMID: 17346540 DOI: 10.1016/j.ajog.2006.10.872] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
11 Wolstencroft KJ, Stevens R, Tabernero L, Brass A. PhosphaBase: An ontology-driven database resource for protein phosphatases. Proteins 2005;58:290-4. [DOI: 10.1002/prot.20325] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
12 Gammon A, Jasperson K, Kohlmann W, Burt RW. Hamartomatous polyposis syndromes. Best Pract Res Clin Gastroenterol 2009;23:219-31. [PMID: 19414148 DOI: 10.1016/j.bpg.2009.02.007] [Cited by in Crossref: 88] [Cited by in F6Publishing: 59] [Article Influence: 7.3] [Reference Citation Analysis]
13 King JS, Teo R, Ryves J, Reddy JV, Peters O, Orabi B, Hoeller O, Williams RS, Harwood AJ. The mood stabiliser lithium suppresses PIP3 signalling in Dictyostelium and human cells. Dis Model Mech 2009;2:306-12. [PMID: 19383941 DOI: 10.1242/dmm.001271] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
14 Baba M, Schmidt LS, Linehan WM. Hereditary Renal Cell Carcinoma. In: Oya M, editor. Renal Cell Carcinoma. Tokyo: Springer Japan; 2017. pp. 19-82. [DOI: 10.1007/978-4-431-55531-5_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Lucci-Cordisco E, Risio M, Venesio T, Genuardi M. The growing complexity of the intestinal polyposis syndromes. Am J Med Genet A. 2013;161A:2777-2787. [PMID: 24124059 DOI: 10.1002/ajmg.a.36253] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
16 Pezzolesi MG, Li Y, Zhou XP, Pilarski R, Shen L, Eng C. Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes. Am J Hum Genet. 2006;79:923-934. [PMID: 17033968 DOI: 10.1086/508943] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
17 Chang CJ, Mulholland DJ, Valamehr B, Mosessian S, Sellers WR, Wu H. PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression. Mol Cell Biol 2008;28:3281-9. [PMID: 18332125 DOI: 10.1128/MCB.00310-08] [Cited by in Crossref: 97] [Cited by in F6Publishing: 64] [Article Influence: 7.5] [Reference Citation Analysis]
18 Lodish MB, Stratakis CA. The differential diagnosis of familial lentiginosis syndromes. Fam Cancer 2011;10:481-90. [PMID: 21538076 DOI: 10.1007/s10689-011-9446-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
19 Przybycin CG, Magi-Galluzzi C, McKenney JK. Hereditary syndromes with associated renal neoplasia: a practical guide to histologic recognition in renal tumor resection specimens. Adv Anat Pathol 2013;20:245-63. [PMID: 23752087 DOI: 10.1097/PAP.0b013e318299b7c6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
20 Yehia L, Ngeow J, Eng C. PTEN-opathies: from biological insights to evidence-based precision medicine. J Clin Invest 2019;129:452-64. [PMID: 30614812 DOI: 10.1172/JCI121277] [Cited by in Crossref: 64] [Cited by in F6Publishing: 37] [Article Influence: 32.0] [Reference Citation Analysis]
21 Okumura K, Mendoza M, Bachoo RM, DePinho RA, Cavenee WK, Furnari FB. PCAF modulates PTEN activity. J Biol Chem 2006;281:26562-8. [PMID: 16829519 DOI: 10.1074/jbc.M605391200] [Cited by in Crossref: 141] [Cited by in F6Publishing: 81] [Article Influence: 9.4] [Reference Citation Analysis]
22 Chmielewska JJ, Burkardt D, Granadillo JL, Slaugh R, Morgan S, Rotenberg J, Keren B, Mignot C, Escobar L, Turnpenny P, Zuteck M, Seaver LH, Ploski R, Dziembowska M, Wynshaw-Boris A, Adegbola A. PTPN4 germline variants result in aberrant neurodevelopment and growth. HGG Adv 2021;2:100033. [PMID: 34527963 DOI: 10.1016/j.xhgg.2021.100033] [Reference Citation Analysis]
23 Galatola M, Paparo L, Duraturo F, Turano M, Rossi GB, Izzo P, De Rosa M. Beta catenin and cytokine pathway dysregulation in patients with manifestations of the “PTEN hamartoma tumor syndrome”. BMC Med Genet. 2012;13:28. [PMID: 22520842 DOI: 10.1186/1471-2350-13-28] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
24 Graham K, Olson MF. The Ras Signalling Pathway as a Target in Cancer Therapy. In: Groner B, editor. Targeted Interference with Signal Transduction Events. Berlin: Springer Berlin Heidelberg; 2007. pp. 125-53. [DOI: 10.1007/978-3-540-31209-3_8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
25 Xing M. The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer. Clin Endocrinol (Oxf) 2005;63:263-6. [PMID: 16117812 DOI: 10.1111/j.1365-2265.2005.02332.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
26 Wang W, Lazar A. Diseases of collagen and elastic tissue. McKee's Pathology of the Skin. Elsevier; 2012. pp. 935-66. [DOI: 10.1016/b978-1-4160-5649-2.00021-4] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
27 Chen R, Zhang M, Liu W, Chen H, Cai T, Xiong H, Sheng X, Liu S, Peng J, Wang F, Chen H, Lin W, Xu X, Zheng W, Jiang Q. Estrogen affects the negative feedback loop of PTENP1-miR200c to inhibit PTEN expression in the development of endometrioid endometrial carcinoma. Cell Death Dis 2018;10:4. [PMID: 30584245 DOI: 10.1038/s41419-018-1207-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
28 Landry CS, Waguespack SG, Perrier ND. Surgical management of nonmultiple endocrine neoplasia endocrinopathies: state-of-the-art review. Surg Clin North Am 2009;89:1069-89. [PMID: 19836485 DOI: 10.1016/j.suc.2009.06.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
29 Pezzolesi MG, Zbuk KM, Waite KA, Eng C. Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome. Hum Mol Genet 2007;16:1058-71. [PMID: 17341483 DOI: 10.1093/hmg/ddm053] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
30 Baba M, Hong SB, Sharma N, Warren MB, Nickerson ML, Iwamatsu A, Esposito D, Gillette WK, Hopkins RF 3rd, Hartley JL, Furihata M, Oishi S, Zhen W, Burke TR Jr, Linehan WM, Schmidt LS, Zbar B. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci U S A 2006;103:15552-7. [PMID: 17028174 DOI: 10.1073/pnas.0603781103] [Cited by in Crossref: 333] [Cited by in F6Publishing: 289] [Article Influence: 22.2] [Reference Citation Analysis]
31 Rademacher S, Detering NT, Schüning T, Lindner R, Santonicola P, Wefel IM, Dehus J, Walter LM, Brinkmann H, Niewienda A, Janek K, Varela MA, Bowerman M, Di Schiavi E, Claus P. A Single Amino Acid Residue Regulates PTEN-Binding and Stability of the Spinal Muscular Atrophy Protein SMN. Cells 2020;9:E2405. [PMID: 33153033 DOI: 10.3390/cells9112405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Zhang R, Banik NL, Ray SK. Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells. Cancer Chemother Pharmacol. 2008;62:407-416. [PMID: 17960384 DOI: 10.1007/s00280-007-0619-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
33 Vernooij M, Claessens T, Luijten M, van Steensel MAM, Coull BJ. Birt–Hogg–Dubé syndrome and the skin. Familial Cancer 2013;12:381-5. [DOI: 10.1007/s10689-013-9600-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
34 Burgucu D, Guney K, Sahinturk D, Ozbudak IH, Ozel D, Ozbilim G, Yavuzer U. Tbx3 represses PTEN and is over-expressed in head and neck squamous cell carcinoma. BMC Cancer 2012;12:481. [PMID: 23082988 DOI: 10.1186/1471-2407-12-481] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
35 Greene AK, Orbach DB. Management of Arteriovenous Malformations. Clinics in Plastic Surgery 2011;38:95-106. [DOI: 10.1016/j.cps.2010.08.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
36 Ferran M, Bussaglia E, Matias-guiu X, Pujol RM. Bilateral and symmetrical palmoplantar punctate keratoses in childhood: a possible clinical clue for an early diagnosis of PTEN hamartoma-tumour syndrome. Clinical and Experimental Dermatology 2009;34:e28-30. [DOI: 10.1111/j.1365-2230.2008.03136.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
37 Bononi A, Pinton P. Study of PTEN subcellular localization. Methods 2015;77-78:92-103. [PMID: 25312582 DOI: 10.1016/j.ymeth.2014.10.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
38 Randall LM, Pothuri B. The genetic prediction of risk for gynecologic cancers. Gynecol Oncol 2016;141:10-6. [PMID: 27016223 DOI: 10.1016/j.ygyno.2016.03.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
39 Lee K, Nam KT, Cho SH, Gudapati P, Hwang Y, Park DS, Potter R, Chen J, Volanakis E, Boothby M. Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia. J Exp Med 2012;209:713-28. [PMID: 22473959 DOI: 10.1084/jem.20111470] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 9.6] [Reference Citation Analysis]
40 Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JGR, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, Ashwell RIS, Ambrose KD, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Bates K, Beasley H, Bray-allen S, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Cahill P, Camire D, Carter NP, Chapman JC, Clark SY, Clarke G, Clee CM, Clegg S, Corby N, Coulson A, Dhami P, Dutta I, Dunn M, Faulkner L, Frankish A, Frankland JA, Garner P, Garnett J, Gribble S, Griffiths C, Grocock R, Gustafson E, Hammond S, Harley JL, Hart E, Heath PD, Ho TP, Hopkins B, Horne J, Howden PJ, Huckle E, Hynds C, Johnson C, Johnson D, Kana A, Kay M, Kimberley AM, Kershaw JK, Kokkinaki M, Laird GK, Lawlor S, Lee HM, Leongamornlert DA, Laird G, Lloyd C, Lloyd DM, Loveland J, Lovell J, Mclaren S, Mclay KE, Mcmurray A, Mashreghi-mohammadi M, Matthews L, Milne S, Nickerson T, Nguyen M, Overton-larty E, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter K, Rice CM, Rogosin A, Ross MT, Sarafidou T, Sehra HK, Shownkeen R, Skuce CD, Smith M, Standring L, Sycamore N, Tester J, Thorpe A, Torcasso W, Tracey A, Tromans A, Tsolas J, Wall M, Walsh J, Wang H, Weinstock K, West AP, Willey DL, Whitehead SL, Wilming L, Wray PW, Young L, Chen Y, Lovering RC, Moschonas NK, Siebert R, Fechtel K, Bentley D, Durbin R, Hubbard T, Doucette-stamm L, Beck S, Smith DR, Rogers J. The DNA sequence and comparative analysis of human chromosome 10. Nature 2004;429:375-81. [DOI: 10.1038/nature02462] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
41 Ostendorf AP, Wong M. mTOR inhibition in epilepsy: rationale and clinical perspectives. CNS Drugs 2015;29:91-9. [PMID: 25633849 DOI: 10.1007/s40263-014-0223-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
42 Yasuda MT, Sakakibara H, Shimoi K. Estrogen- and stress-induced DNA damage in breast cancer and chemoprevention with dietary flavonoid. Genes Environ 2017;39:10. [PMID: 28163803 DOI: 10.1186/s41021-016-0071-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
43 Steelman LS, Navolanic PM, Sokolosky ML, Taylor JR, Lehmann BD, Chappell WH, Abrams SL, Wong EW, Stadelman KM, Terrian DM, Leslie NR, Martelli AM, Stivala F, Libra M, Franklin RA, McCubrey JA. Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors. Oncogene 2008;27:4086-95. [PMID: 18332865 DOI: 10.1038/onc.2008.49] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 8.2] [Reference Citation Analysis]
44 Hayes MN, Langenau DM. Discovering novel oncogenic pathways and new therapies using zebrafish models of sarcoma. Methods Cell Biol 2017;138:525-61. [PMID: 28129857 DOI: 10.1016/bs.mcb.2016.11.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
45 Mirzaa GM, Paciorkowski AR, Smyser CD, Willing MC, Lind AC, Dobyns WB. The microcephaly-capillary malformation syndrome. Am J Med Genet A 2011;155A:2080-7. [PMID: 21815250 DOI: 10.1002/ajmg.a.34118] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
46 Park JY, Lin PY, Weiss RH. Targeting the PI3K-Akt pathway in kidney cancer. Expert Rev Anticancer Ther 2007;7:863-70. [PMID: 17555396 DOI: 10.1586/14737140.7.6.863] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
47 Alomari AI. Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome. Clin Dysmorphol. 2009;18:1-7. [PMID: 19011570 DOI: 10.1097/mcd.0b013e328317a716] [Cited by in Crossref: 107] [Cited by in F6Publishing: 25] [Article Influence: 8.9] [Reference Citation Analysis]
48 Yakubov E, Ghoochani A, Buslei R, Buchfelder M, Eyüpoglu IY, Savaskan N. Hidden association of Cowden syndrome, PTEN mutation and meningioma frequency. Oncoscience 2016;3:149-55. [PMID: 27489861 DOI: 10.18632/oncoscience.305] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
49 Choorapoikayil S, Kuiper RV, de Bruin A, den Hertog J. Haploinsufficiency of the genes encoding the tumor suppressor Pten predisposes zebrafish to hemangiosarcoma. Dis Model Mech 2012;5:241-7. [PMID: 22071262 DOI: 10.1242/dmm.008326] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
50 Renner O, Fominaya J, Alonso S, Blanco-Aparicio C, Leal JF, Carnero A. Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. Carcinogenesis 2007;28:1418-25. [PMID: 17372272 DOI: 10.1093/carcin/bgm059] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
51 Hammes SR, Levin ER. Extranuclear steroid receptors: nature and actions. Endocr Rev 2007;28:726-41. [PMID: 17916740 DOI: 10.1210/er.2007-0022] [Cited by in Crossref: 331] [Cited by in F6Publishing: 320] [Article Influence: 23.6] [Reference Citation Analysis]
52 Mauro A, Omoyinmi E, Sebire NJ, Barnicoat A, Brogan P. De Novo PTEN Mutation in a Young Boy with Cutaneous Vasculitis. Case Rep Pediatr 2017;2017:9682803. [PMID: 28523199 DOI: 10.1155/2017/9682803] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
53 Mishra RR, Chaudhary JK, Bajaj GD, Rath PC. A novel human TPIP splice-variant (TPIP-C2) mRNA, expressed in human and mouse tissues, strongly inhibits cell growth in HeLa cells. PLoS One 2011;6:e28433. [PMID: 22164291 DOI: 10.1371/journal.pone.0028433] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
54 Haddadi N, Travis G, Nassif NT, Simpson AM, Marsh DJ. Toward Systems Pathology for PTEN Diagnostics. Cold Spring Harb Perspect Med 2020;10:a037127. [PMID: 31615872 DOI: 10.1101/cshperspect.a037127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
55 Carvalho KC, Maia BM, Omae SV, Rocha AA, Covizzi LP, Vassallo J, Rocha RM, Soares FA. Best practice for PTEN gene and protein assessment in anatomic pathology. Acta Histochemica 2014;116:25-31. [DOI: 10.1016/j.acthis.2013.04.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
56 Zhu L, Zhao S, Liu S, Liu Q, Li F, Hao J. PTEN Regulates Renal Extracellular Matrix Deposit via Increased CTGF in Diabetes Mellitus. J Cell Biochem 2016;117:1187-98. [PMID: 26447680 DOI: 10.1002/jcb.25402] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
57 Siggberg L, Ala-Mello S, Jaakkola E, Kuusinen E, Schuit R, Kohlhase J, Böhm D, Ignatius J, Knuutila S. Array CGH in molecular diagnosis of mental retardation - A study of 150 Finnish patients. Am J Med Genet A 2010;152A:1398-410. [PMID: 20503314 DOI: 10.1002/ajmg.a.33402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 0.2] [Reference Citation Analysis]
58 Scherbakova EA, Stromskaya TP, Rybalkina EY, Kalita OV, Stavrovskaya AA. Role of the PTEN protein in the multidrug resistance of prostate cancer cells. Mol Biol 2008;42:430-5. [DOI: 10.1134/s0026893308030114] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
59 Wang Y, Romigh T, He X, Orloff MS, Silverman RH, Heston WD, Eng C. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines. Hum Mol Genet. 2010;19:4319-4329. [PMID: 20729295 DOI: 10.1093/hmg/ddq354] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 5.7] [Reference Citation Analysis]
60 Hay N. The Akt-mTOR tango and its relevance to cancer. Cancer Cell. 2005;8:179-183. [PMID: 16169463 DOI: 10.1016/j.ccr.2005.08.008] [Cited by in Crossref: 545] [Cited by in F6Publishing: 514] [Article Influence: 34.1] [Reference Citation Analysis]
61 Lieberman-Cribbin W, Tuminello S, Gillezeau C, van Gerwen M, Brody R, Mulholland DJ, Horton L, Sisco M, Prophete C, Zelikoff J, Lee HW, Park SH, Chen LC, Cohen MD, Taioli E. Complementary biobank of rodent tissue samples to study the effect of World Trade Center exposure on cancer development. J Transl Med 2019;17:342. [PMID: 31601237 DOI: 10.1186/s12967-019-2089-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Castaneda CA, Cortes-Funes H, Gomez HL, Ciruelos EM. The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer. Cancer Metastasis Rev. 2010;29:751-759. [PMID: 20922461 DOI: 10.1007/s10555-010-9261-0] [Cited by in Crossref: 103] [Cited by in F6Publishing: 105] [Article Influence: 10.3] [Reference Citation Analysis]
63 Dhamija R, Hoxworth JM. Imaging of PTEN-related abnormalities in the central nervous system. Clin Imaging 2020;60:180-5. [PMID: 31927175 DOI: 10.1016/j.clinimag.2019.12.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
64 Briercheck EL, Trotta R, Chen L, Hartlage AS, Cole JP, Cole TD, Mao C, Banerjee PP, Hsu HT, Mace EM, Ciarlariello D, Mundy-Bosse BL, Garcia-Cao I, Scoville SD, Yu L, Pilarski R, Carson WE 3rd, Leone G, Pandolfi PP, Yu J, Orange JS, Caligiuri MA. PTEN is a negative regulator of NK cell cytolytic function. J Immunol 2015;194:1832-40. [PMID: 25595786 DOI: 10.4049/jimmunol.1401224] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
65 De Rosa M, Rega D, Costabile V, Duraturo F, Niglio A, Izzo P, Pace U, Delrio P. The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care. Therap Adv Gastroenterol 2016;9:861-86. [PMID: 27803741 DOI: 10.1177/1756283X16659790] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
66 Lin PY, Fosmire SP, Park SH, Park JY, Baksh S, Modiano JF, Weiss RH. Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance. Mol Cancer. 2007;6:16. [PMID: 17300726 DOI: 10.1186/1476-4598-6-16] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
67 Song MS, Salmena L, Carracedo A, Egia A, Lo-Coco F, Teruya-Feldstein J, Pandolfi PP. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature. 2008;455:813-817. [PMID: 18716620 DOI: 10.1038/nature07290] [Cited by in Crossref: 351] [Cited by in F6Publishing: 335] [Article Influence: 27.0] [Reference Citation Analysis]
68 Persico AM, Cucinotta F, Ricciardello A, Turriziani L. Autisms. Neurodevelopmental Disorders. Elsevier; 2020. pp. 35-77. [DOI: 10.1016/b978-0-12-814409-1.00003-3] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
69 Teresi RE, Shaiu CW, Chen CS, Chatterjee VK, Waite KA, Eng C. Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone. Int J Cancer. 2006;118:2390-2398. [PMID: 16425225 DOI: 10.1002/ijc.21799] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 5.3] [Reference Citation Analysis]
70 Leo A, Constanti A, Coppola A, Citraro R, De Sarro G, Russo E. mTOR Signaling in Epilepsy and Epileptogenesis. Molecules to Medicine with mTOR. Elsevier; 2016. pp. 123-42. [DOI: 10.1016/b978-0-12-802733-2.00006-2] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
71 Corradetti MN, Inoki K, Bardeesy N, DePinho RA, Guan KL. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev 2004;18:1533-8. [PMID: 15231735 DOI: 10.1101/gad.1199104] [Cited by in Crossref: 394] [Cited by in F6Publishing: 365] [Article Influence: 23.2] [Reference Citation Analysis]
72 Dong HY, Zeng H, Hu YQ, Xie L, Wang J, Wang XY, Yang YF, Tan ZP. 19p13.2 Microdeletion including NFIX associated with overgrowth and intellectual disability suggestive of Malan syndrome. Mol Cytogenet 2016;9:71. [PMID: 27688808 DOI: 10.1186/s13039-016-0282-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
73 Nosé V. Familial Non-Medullary Thyroid Carcinoma: An Update. Endocr Pathol 2008;19:226-40. [DOI: 10.1007/s12022-008-9045-z] [Cited by in Crossref: 57] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
74 Zagni C, Pistarà V, Oliveira LA, Castilho RM, Romeo G, Chiacchio U, Rescifina A. Serendipitous discovery of potent human head and neck squamous cell carcinoma anti-cancer molecules: A fortunate failure of a rational molecular design. Eur J Med Chem 2017;141:188-96. [PMID: 29031066 DOI: 10.1016/j.ejmech.2017.09.075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
75 Agrawal S, Pilarski R, Eng C. Different splicing defects lead to differential effects downstream of the lipid and protein phosphatase activities of PTEN. Human Molecular Genetics 2005;14:2459-68. [DOI: 10.1093/hmg/ddi246] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
76 Yin Y, Shen WH. PTEN: a new guardian of the genome. Oncogene 2008;27:5443-53. [PMID: 18794879 DOI: 10.1038/onc.2008.241] [Cited by in Crossref: 241] [Cited by in F6Publishing: 234] [Article Influence: 18.5] [Reference Citation Analysis]
77 Mitsiades N, Fagin JA. Molecular Genetics of Thyroid Cancer. Genetic Diagnosis of Endocrine Disorders. Elsevier; 2010. pp. 117-38. [DOI: 10.1016/b978-0-12-374430-2.00011-0] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
78 Mace EM. Phosphoinositide-3-Kinase Signaling in Human Natural Killer Cells: New Insights from Primary Immunodeficiency. Front Immunol 2018;9:445. [PMID: 29563913 DOI: 10.3389/fimmu.2018.00445] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
79 Pavlović M, Neubauer D, Al Tawari A, Heberle LC. The Microcephaly-Capillary Malformation Syndrome in Two Brothers With Novel Clinical Features. Pediatric Neurology 2014;51:560-5. [DOI: 10.1016/j.pediatrneurol.2014.07.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
80 Al-Zaid T, Ditelberg JS, Prieto VG, Lev D, Luthra R, Davies MA, Diwan AH, Wang WL, Lazar AJ. Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors. J Cutan Pathol 2012;39:493-9. [PMID: 22486434 DOI: 10.1111/j.1600-0560.2012.01888.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
81 Hariri OR, Khachekian A, Muilli D, Amin J, Minassian T, Berman B, Ritter Y, Siddiqi J. Acute-Onset Cerebellar Symptoms in Lhermitte–Duclos Disease: Case Report. Cerebellum 2013;12:127-30. [DOI: 10.1007/s12311-012-0394-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
82 Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, Yang H, Pavletich NP, Carver BS, Cordon-Cardo C, Erdjument-Bromage H. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell. 2007;128:141-156. [PMID: 17218261 DOI: 10.1016/j.cell.2006.11.040] [Cited by in Crossref: 495] [Cited by in F6Publishing: 493] [Article Influence: 35.4] [Reference Citation Analysis]
83 Bao W, Florea L, Wu N, Wang Z, Banaudha K, Qian J, Houzet L, Kumar R, Kumar A. Loss of nuclear PTEN in HCV-infected human hepatocytes. Infect Agent Cancer 2014;9:23. [PMID: 25075209 DOI: 10.1186/1750-9378-9-23] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
84 Kim CS, Vasko VV, Kato Y, Kruhlak M, Saji M, Cheng SY, Ringel MD. AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma. Endocrinology. 2005;146:4456-4463. [PMID: 16002527 DOI: 10.1210/en.2005-0172] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 4.2] [Reference Citation Analysis]
85 Marsit CJ, Zheng S, Aldape K, Hinds PW, Nelson HH, Wiencke JK, Kelsey KT. PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Hum Pathol 2005;36:768-76. [PMID: 16084946 DOI: 10.1016/j.humpath.2005.05.006] [Cited by in Crossref: 173] [Cited by in F6Publishing: 174] [Article Influence: 10.8] [Reference Citation Analysis]
86 Malan V, Chevallier S, Soler G, Coubes C, Lacombe D, Pasquier L, Soulier J, Morichon-Delvallez N, Turleau C, Munnich A, Romana S, Vekemans M, Cormier-Daire V, Colleaux L. Array-based comparative genomic hybridization identifies a high frequency of copy number variations in patients with syndromic overgrowth. Eur J Hum Genet 2010;18:227-32. [PMID: 19844265 DOI: 10.1038/ejhg.2009.162] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
87 Saavedra L, Catarino R, Heinz T, Heilmann I, Bezanilla M, Malhó R. Phosphatase and Tensin Homolog Is a Growth Repressor of Both Rhizoid and Gametophore Development in the Moss Physcomitrella patens. Plant Physiol 2015;169:2572-86. [PMID: 26463087 DOI: 10.1104/pp.15.01197] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
88 Milella M, Ciuffreda L, Bria E. Signal Transduction Pathways as Therapeutic Targets in Cancer Therapy. In: Reddy LH, Couvreur P, editors. Macromolecular Anticancer Therapeutics. New York: Springer; 2010. pp. 37-83. [DOI: 10.1007/978-1-4419-0507-9_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
89 Mester J, Eng C. Cowden syndrome: Recognizing and managing a not-so-rare hereditary cancer syndrome: Cowden Syndrome. J Surg Oncol 2015;111:125-30. [DOI: 10.1002/jso.23735] [Cited by in Crossref: 81] [Cited by in F6Publishing: 51] [Article Influence: 11.6] [Reference Citation Analysis]
90 Leslie NR, Spinelli L, Tibarewal P, Zilidis G, Weerasinghe N, Lim JC, Maccario H, Downes CP. Indirect mechanisms of carcinogenesis via downregulation of PTEN function. Adv Enzyme Regul 2010;50:112-8. [PMID: 19895830 DOI: 10.1016/j.advenzreg.2009.10.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
91 Chia JY, Gajewski JE, Xiao Y, Zhu H, Cheng H. Unique biochemical properties of the protein tyrosine phosphatase activity of PTEN—Demonstration of different active site structural requirements for phosphopeptide and phospholipid phosphatase activities of PTEN. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2010;1804:1785-95. [DOI: 10.1016/j.bbapap.2010.05.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
92 Torres VE, Boletta A, Chapman A, Gattone V, Pei Y, Qian Q, Wallace DP, Weimbs T, Wüthrich RP. Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases. Clin J Am Soc Nephrol 2010;5:1312-29. [PMID: 20498248 DOI: 10.2215/CJN.01360210] [Cited by in Crossref: 75] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
93 Dowhan DH, Harrison MJ, Eriksson NA, Bailey P, Pearen MA, Fuller PJ, Funder JW, Simpson ER, Leedman PJ, Tilley WD, Brown MA, Clarke CL, Muscat GEO. Protein arginine methyltransferase 6-dependent gene expression and splicing: association with breast cancer outcomes. Endocrine-Related Cancer 2012;19:509-26. [DOI: 10.1530/erc-12-0100] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
94 Hu ZI, Bangiyev L, Seidman RJ, Cohen JA. Dysphagia and Neck Swelling in a Case of Undiagnosed Lhermitte-Duclos Disease and Cowden Syndrome. Case Rep Oncol Med 2015;2015:546297. [PMID: 26448889 DOI: 10.1155/2015/546297] [Reference Citation Analysis]
95 Thiffault I, Schwartz CE, Der Kaloustian V, Foulkes WD. Mutation analysis of the tumor suppressor PTEN and the glypican 3 (GPC3) gene in patients diagnosed with Proteus syndrome. Am J Med Genet A 2004;130A:123-7. [PMID: 15372512 DOI: 10.1002/ajmg.a.30335] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
96 Furuya F, Hanover JA, Cheng SY. Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor. Proc Natl Acad Sci U S A 2006;103:1780-5. [PMID: 16446424 DOI: 10.1073/pnas.0510849103] [Cited by in Crossref: 113] [Cited by in F6Publishing: 107] [Article Influence: 7.5] [Reference Citation Analysis]
97 Haynie DT, Xue B. Superdomains in the protein structure hierarchy: The case of PTP-C2. Protein Sci 2015;24:874-82. [PMID: 25694109 DOI: 10.1002/pro.2664] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
98 Abdel-Rahman MH, Yang Y, Zhou XP, Craig EL, Davidorf FH, Eng C. High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma. J Clin Oncol 2006;24:288-95. [PMID: 16344319 DOI: 10.1200/JCO.2005.02.2418] [Cited by in Crossref: 79] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
99 Doxey BW, Kuwada SK, Burt RW. Inherited Polyposis Syndromes: Molecular Mechanisms, Clinicopathology, and Genetic Testing. Clinical Gastroenterology and Hepatology 2005;3:633-41. [DOI: 10.1016/s1542-3565(05)00370-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 4] [Article Influence: 2.1] [Reference Citation Analysis]
100 Wilhelm F, Kässner F, Schmid G, Kratzsch J, Laner A, Wabitsch M, Körner A, Kiess W, Garten A. Phosphatidylinositol 3-kinase (PI3K) signalling regulates insulin-like-growth factor binding protein-2 (IGFBP-2) production in human adipocytes. Growth Horm IGF Res 2015;25:115-20. [PMID: 25900365 DOI: 10.1016/j.ghir.2015.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
101 Moesslacher CS, Kohlmayr JM, Stelzl U. Exploring absent protein function in yeast: assaying post translational modification and human genetic variation. Microb Cell 2021;8:164-83. [PMID: 34395585 DOI: 10.15698/mic2021.08.756] [Reference Citation Analysis]
102 Napoli E, Ross-Inta C, Wong S, Hung C, Fujisawa Y, Sakaguchi D, Angelastro J, Omanska-Klusek A, Schoenfeld R, Giulivi C. Mitochondrial dysfunction in Pten haplo-insufficient mice with social deficits and repetitive behavior: interplay between Pten and p53. PLoS One 2012;7:e42504. [PMID: 22900024 DOI: 10.1371/journal.pone.0042504] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 7.9] [Reference Citation Analysis]
103 Yue Q, Groszer M, Gil JS, Berk AJ, Messing A, Wu H, Liu X. PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization. Development 2005;132:3281-91. [PMID: 15944184 DOI: 10.1242/dev.01891] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 4.3] [Reference Citation Analysis]
104 Linehan WM, Ricketts CJ. The metabolic basis of kidney cancer. Semin Cancer Biol 2013;23:46-55. [PMID: 22705279 DOI: 10.1016/j.semcancer.2012.06.002] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 9.0] [Reference Citation Analysis]
105 Woodhouse JB, Delahunt B, English SF, Fraser HH, Ferguson MM. Testicular lipomatosis in Cowden's syndrome. Mod Pathol 2005;18:1151-6. [PMID: 15920539 DOI: 10.1038/modpathol.3800448] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
106 Leslie NR, Longy M. Inherited PTEN mutations and the prediction of phenotype. Seminars in Cell & Developmental Biology 2016;52:30-8. [DOI: 10.1016/j.semcdb.2016.01.030] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 10.8] [Reference Citation Analysis]
107 Vargas AC, Reis-Filho JS, Lakhani SR. Phenotype-genotype correlation in familial breast cancer. J Mammary Gland Biol Neoplasia 2011;16:27-40. [PMID: 21400086 DOI: 10.1007/s10911-011-9204-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
108 Ali E, Athanasopoulos PG, Forouhi P, Malata CM. Cowden syndrome and reconstructive breast surgery: case reports and review of the literature. J Plast Reconstr Aesthet Surg 2011;64:545-9. [PMID: 20627761 DOI: 10.1016/j.bjps.2010.04.047] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
109 Khadir K, Eddaoui A, Chiheb S, Bourhnane D, Chaffik N, Azzouzi S, Benchikhi H. [Fatal progression of Bannayan-Zonana syndrome]. Arch Pediatr 2009;16:364-7. [PMID: 19261453 DOI: 10.1016/j.arcped.2009.01.003] [Reference Citation Analysis]
110 Natali D, Girerd B, Montani D, Soubrier F, Simonneau G, Humbert M, Sitbon O. Pulmonary arterial hypertension in a patient with Cowden syndrome and anorexigen exposure. Chest 2011;140:1066-8. [PMID: 21972386 DOI: 10.1378/chest.10-2588] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
111 Bilbao C, Rodríguez G, Ramírez R, Falcón O, León L, Chirino R, Rivero JF, Falcón O, Díaz-Chico BN, Díaz-Chico JC. The relationship between microsatellite instability and PTEN gene mutations in endometrial cancer. Int J Cancer. 2006;119:563-570. [PMID: 16506206 DOI: 10.1002/ijc.21862] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
112 . Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793. Obstetrics & Gynecology 2019;134:e143-9. [DOI: 10.1097/aog.0000000000003562] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 5.5] [Reference Citation Analysis]
113 Bahk YY, Cho I, Kim TS. A Cross-talk between oncogenic Ras and tumor suppressor PTEN through FAK Tyr861 phosphorylation in NIH/3T3 mouse embryonic fibroblasts. Biochemical and Biophysical Research Communications 2008;377:1199-204. [DOI: 10.1016/j.bbrc.2008.10.157] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
114 Holman JD, Dyer JA. Genodermatoses with malignant potential. Current Opinion in Pediatrics 2007;19:446-54. [DOI: 10.1097/mop.0b013e3282495939] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
115 Zafeiriou DI, Ververi A, Vargiami E. Childhood autism and associated comorbidities. Brain Dev 2007;29:257-72. [PMID: 17084999 DOI: 10.1016/j.braindev.2006.09.003] [Cited by in Crossref: 103] [Cited by in F6Publishing: 84] [Article Influence: 6.9] [Reference Citation Analysis]
116 Nosé V. Thyroid cancer of follicular cell origin in inherited tumor syndromes. Adv Anat Pathol 2010;17:428-36. [PMID: 20966648 DOI: 10.1097/PAP.0b013e3181f8b028] [Cited by in Crossref: 40] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
117 Blando J, Portis M, Benavides F, Alexander A, Mills G, Dave B, Conti CJ, Kim J, Walker CL. PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth. Am J Pathol 2009;174:1869-79. [PMID: 19395652 DOI: 10.2353/ajpath.2009.080055] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
118 Tsujita Y, Mitsui-Sekinaka K, Imai K, Yeh TW, Mitsuiki N, Asano T, Ohnishi H, Kato Z, Sekinaka Y, Zaha K, Kato T, Okano T, Takashima T, Kobayashi K, Kimura M, Kunitsu T, Maruo Y, Kanegane H, Takagi M, Yoshida K, Okuno Y, Muramatsu H, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Kojima S, Ogawa S, Ohara O, Okada S, Kobayashi M, Morio T, Nonoyama S. Phosphatase and tensin homolog (PTEN) mutation can cause activated phosphatidylinositol 3-kinase δ syndrome-like immunodeficiency. J Allergy Clin Immunol 2016;138:1672-1680.e10. [PMID: 27426521 DOI: 10.1016/j.jaci.2016.03.055] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 11.8] [Reference Citation Analysis]
119 Hursting SD, Lashinger LM, Wheatley KW, Rogers CJ, Colbert LH, Nunez NP, Perkins SN. Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link. Best Pract Res Clin Endocrinol Metab 2008;22:659-69. [PMID: 18971125 DOI: 10.1016/j.beem.2008.08.009] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 6.3] [Reference Citation Analysis]
120 Bian Y, Terse A, Du J, Hall B, Molinolo A, Zhang P, Chen W, Flanders KC, Gutkind JS, Wakefield LM, Kulkarni AB. Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway. Cancer Res 2009;69:5918-26. [PMID: 19584284 DOI: 10.1158/0008-5472.CAN-08-4623] [Cited by in Crossref: 67] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
121 Kim DS, Lee SM, Yoon GS, Choi JE, Park JY. Infrequent hypermethylation of the PTEN gene in Korean non-small-cell lung cancers. Cancer Sci. 2010;101:568-572. [PMID: 20175786 DOI: 10.1111/j.1349-7006.2009.01406.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
122 Vasovčák P, Senkeříková M, Hatlová J, Křepelová A. Multiple primary malignancies and subtle mucocutaneous lesions associated with a novel PTEN gene mutation in a patient with Cowden syndrome: case report. BMC Med Genet 2011;12:38. [PMID: 21406108 DOI: 10.1186/1471-2350-12-38] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
123 Kim JH, Chu SC, Gramlich JL, Pride YB, Babendreier E, Chauhan D, Salgia R, Podar K, Griffin JD, Sattler M. Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species. Blood 2005;105:1717-23. [PMID: 15486067 DOI: 10.1182/blood-2004-03-0849] [Cited by in Crossref: 156] [Cited by in F6Publishing: 153] [Article Influence: 9.2] [Reference Citation Analysis]
124 Salviati L, Patricelli M, Guariso G, Sturniolo GC, Alaggio R, Bernardi F, Zuffardi O, Tenconi R. Deletion of PTEN and BMPR1A on chromosome 10q23 is not always associated with juvenile polyposis of infancy. Am J Hum Genet. 2006;79:593-56; author reply 593-56;. [PMID: 16909400 DOI: 10.1086/507151] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
125 Manning BD, Logsdon MN, Lipovsky AI, Abbott D, Kwiatkowski DJ, Cantley LC. Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev 2005;19:1773-8. [PMID: 16027169 DOI: 10.1101/gad.1314605] [Cited by in Crossref: 179] [Cited by in F6Publishing: 174] [Article Influence: 11.2] [Reference Citation Analysis]
126 Zbuk KM, Eng C. Cancer phenomics: RET and PTEN as illustrative models. Nat Rev Cancer 2007;7:35-45. [PMID: 17167516 DOI: 10.1038/nrc2037] [Cited by in Crossref: 177] [Cited by in F6Publishing: 150] [Article Influence: 11.8] [Reference Citation Analysis]
127 Garcia-Cao I, Song MS, Hobbs RM, Laurent G, Giorgi C, de Boer VC, Anastasiou D, Ito K, Sasaki AT, Rameh L, Carracedo A, Vander Heiden MG, Cantley LC, Pinton P, Haigis MC, Pandolfi PP. Systemic elevation of PTEN induces a tumor-suppressive metabolic state. Cell 2012;149:49-62. [PMID: 22401813 DOI: 10.1016/j.cell.2012.02.030] [Cited by in Crossref: 262] [Cited by in F6Publishing: 229] [Article Influence: 29.1] [Reference Citation Analysis]
128 Pimpalwar S, Yoo R, Chau A, Ashton D, Margolin J, Iacobas I. Temporal Evolution and Management of Fast Flow Vascular Anomalies in PTEN Hamartoma Tumor Syndrome. Int J Angiol 2018;27:158-64. [PMID: 30154635 DOI: 10.1055/s-0038-1661377] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
129 Palumbo E, Zhao B, Xue B, Uversky VN, Davé V. Analyzing aggregation propensities of clinically relevant PTEN mutants: a new culprit in pathogenesis of cancer and other PTENopathies. J Biomol Struct Dyn 2020;38:2253-66. [PMID: 31232187 DOI: 10.1080/07391102.2019.1630005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
130 Tate G, Suzuki T, Nemoto H, Kishimoto K, Hibi K, Mitsuya T. Allelic loss of the PTEN gene and mutation of the TP53 gene in choriocarcinoma arising from gastric adenocarcinoma: analysis of loss of heterozygosity in two male patients with extragonadal choriocarcinoma. Cancer Genet Cytogenet. 2009;193:104-108. [PMID: 19665071 DOI: 10.1016/j.cancergencyto.2009.04.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
131 Kwiatkowski DJ. Genetics of Tuberous Sclerosis Complex. In: Kwiatkowski DJ, Whittemore VH, Thiele EA, editors. Tuberous Sclerosis Complex. Wiley; 2010. pp. 27-60. [DOI: 10.1002/9783527630073.ch4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
132 Melbārde-Gorkuša I, Irmejs A, Bērziņa D, Strumfa I, Aboliņš A, Gardovskis A, Subatniece S, Trofimovičs G, Gardovskis J, Miklaševičs E. Challenges in the management of a patient with Cowden syndrome: case report and literature review. Hered Cancer Clin Pract 2012;10:5. [PMID: 22503188 DOI: 10.1186/1897-4287-10-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
133 Steelman LS, Bertrand FE, Mccubrey JA. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention. Expert Opinion on Therapeutic Targets 2005;8:537-50. [DOI: 10.1517/14728222.8.6.537] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 4.6] [Reference Citation Analysis]
134 Cribier B. Papules des extrémités : aspects clinique et histologique. Annales de Dermatologie et de Vénéréologie 2005;132:483-91. [DOI: 10.1016/s0151-9638(05)79316-9] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
135 Navis AC, van den Eijnden M, Schepens JT, Hooft van Huijsduijnen R, Wesseling P, Hendriks WJ. Protein tyrosine phosphatases in glioma biology. Acta Neuropathol 2010;119:157-75. [PMID: 19936768 DOI: 10.1007/s00401-009-0614-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
136 Gajewski JE, Bird MJ, Crowhurst MO, Sio-Seng Lio D, Liu J, Wettenhall RE, Zhu HJ, Cheng HC. Expression, generation, and purification of unphosphorylated and phospho-Ser-380/Thr-382/Thr-383 form of recombinant PTEN phosphatase. Protein Expr Purif 2007;55:334-42. [PMID: 17562371 DOI: 10.1016/j.pep.2007.04.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
137 Bose S, Walts AE. Thyroid Fine Needle Aspirate: A Post-Bethesda Update. Advances in Anatomic Pathology 2012;19:160-9. [DOI: 10.1097/pap.0b013e3182534610] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
138 Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB. Recent advances in thyroid cancer. Curr Probl Surg 2008;45:156-250. [PMID: 18346477 DOI: 10.1067/j.cpsurg.2007.12.010] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
139 Saletti V, Esposito S, Maccaro A, Giglio S, Valentini LG, Chiapparini L. Chiari I malformation in a child with PTEN hamartoma tumor syndrome: Association or coincidence? European Journal of Medical Genetics 2017;60:261-4. [DOI: 10.1016/j.ejmg.2017.03.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
140 Lin MS, Huang JX, Chen WC, Zhang BF, Fang J, Zhou Q, Hu Y, Gao HJ. Expression of PPARγ and PTEN in human colorectal cancer: An immunohistochemical study using tissue microarray methodology. Oncol Lett 2011;2:1219-24. [PMID: 22848291 DOI: 10.3892/ol.2011.414] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
141 Attard TM, Young RJ. Diagnosis and management of gastrointestinal polyps: pediatric considerations. Gastroenterol Nurs 2006;29:16-22; quiz 23-4. [PMID: 16552295 DOI: 10.1097/00001610-200601000-00003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
142 Zbuk KM, Patocs A, Shealy A, Sylvester H, Miesfeldt S, Eng C. Germline mutations in PTEN and SDHC in a woman with epithelial thyroid cancer and carotid paraganglioma. Nat Clin Pract Oncol. 2007;4:608-612. [PMID: 17898811 DOI: 10.1038/ncponc0935] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
143 Dai C, Chung IJ, Krantz SB. Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt/PKB. Exp Hematol 2005;33:152-8. [PMID: 15676208 DOI: 10.1016/j.exphem.2004.10.017] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
144 Johnston SB, Raines RT. Conformational stability and catalytic activity of PTEN variants linked to cancers and autism spectrum disorders. Biochemistry. 2015;54:1576-1582. [PMID: 25647146 DOI: 10.1021/acs.biochem.5b00028] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
145 Puig I, Champeval D, De Santa Barbara P, Jaubert F, Lyonnet S, Larue L. Deletion of Pten in the mouse enteric nervous system induces ganglioneuromatosis and mimics intestinal pseudoobstruction. J Clin Invest 2009;119:3586-96. [PMID: 19884655 DOI: 10.1172/JCI39929] [Cited by in Crossref: 45] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
146 Johnson JL, Pillai S, Chellappan SP. Genetic and biochemical alterations in non-small cell lung cancer. Biochem Res Int 2012;2012:940405. [PMID: 22928112 DOI: 10.1155/2012/940405] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
147 Eng W, Hammill AM, Adams DM. Overgrowth syndromes and new therapies. Seminars in Pediatric Surgery 2020;29:150974. [DOI: 10.1016/j.sempedsurg.2020.150974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Wreesmann VB, Singh B. Clinical Impact of Molecular Analysis on Thyroid Cancer Management. Surgical Oncology Clinics of North America 2008;17:1-35. [DOI: 10.1016/j.soc.2007.10.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
149 de Miguel R, López-gutierrez J, Boixeda P. Malformaciones arteriovenosas: un reto diagnóstico y terapéutico. Actas Dermo-Sifiliográficas 2014;105:347-58. [DOI: 10.1016/j.ad.2013.04.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
150 Liu L, Hu X, Cai GY, Lv Y, Zhuo L, Gao JJ, Cui SY, Feng Z, Fu B, Chen XM. High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 overexpression via PTEN/Akt/mTOR signaling. Nephrol Dial Transplant 2012;27:90-100. [PMID: 21633095 DOI: 10.1093/ndt/gfr265] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
151 Nguyen H, Boon LM, Vikkula M. Genetics of vascular malformations. Seminars in Pediatric Surgery 2014;23:221-6. [DOI: 10.1053/j.sempedsurg.2014.06.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 3.9] [Reference Citation Analysis]
152 Shive HR. Zebrafish Models for Human Cancer. Vet Pathol 2013;50:468-82. [DOI: 10.1177/0300985812467471] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
153 Zhang XM, Liu ZL, Qiu B, Xu YF, Pan C, Zhang ZL. Downregulation of EVI1 Expression Inhibits Cell Proliferation and Induces Apoptosis in Hilar Cholangiocarcinoma via the PTEN/AKT Signalling Pathway. J Cancer 2020;11:1412-23. [PMID: 32047548 DOI: 10.7150/jca.31903] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
154 Sun Z, Ji N, Bi M, Wang S, Liu X, Wang Z. PTEN gene is infrequently hypermethylated in human esophageal squamous cell carcinoma. Tumor Biol 2015;36:5849-57. [DOI: 10.1007/s13277-015-3256-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
155 Dandine JB, James S, Van Garsse A, Born JD. [Intracranial hypertension in Proteus syndrome]. Neurochirurgie 2007;53:339-42. [PMID: 17706728 DOI: 10.1016/j.neuchi.2007.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
156 Liu L, Liao JZ, He XX, Li PY. The role of autophagy in hepatocellular carcinoma: friend or foe. Oncotarget. 2017;8:57707-57722. [PMID: 28915706 DOI: 10.18632/oncotarget.17202] [Cited by in Crossref: 63] [Cited by in F6Publishing: 73] [Article Influence: 15.8] [Reference Citation Analysis]
157 Tate G, Tajiri T, Suzuki T, Mitsuya T. Mutations of the KIT gene and loss of heterozygosity of the PTEN region in a primary malignant melanoma arising from a mature cystic teratoma of the ovary. Cancer Genet Cytogenet. 2009;190:15-20. [PMID: 19264228 DOI: 10.1016/j.cancergencyto.2008.11.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
158 Kreis P, van Diepen MT, Eickholt BJ. Regulation of PTEN in neurons by myosin-based transport mechanisms. Advances in Enzyme Regulation 2010;50:119-24. [DOI: 10.1016/j.advenzreg.2009.10.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
159 Hasumi Y, Baba M, Ajima R, Hasumi H, Valera VA, Klein ME, Haines DC, Merino MJ, Hong SB, Yamaguchi TP, Schmidt LS, Linehan WM. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc Natl Acad Sci U S A 2009;106:18722-7. [PMID: 19850877 DOI: 10.1073/pnas.0908853106] [Cited by in Crossref: 169] [Cited by in F6Publishing: 151] [Article Influence: 14.1] [Reference Citation Analysis]
160 Missiaglia E, Dalai I, Barbi S, Beghelli S, Falconi M, della Peruta M, Piemonti L, Capurso G, Di Florio A, delle Fave G, Pederzoli P, Croce CM, Scarpa A. Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J Clin Oncol. 2010;28:245-255. [PMID: 19917848 DOI: 10.1200/jco.2008.21.5988] [Cited by in Crossref: 362] [Cited by in F6Publishing: 168] [Article Influence: 30.2] [Reference Citation Analysis]
161 Varga EA, Pastore M, Prior T, Herman GE, McBride KL. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med 2009;11:111-7. [PMID: 19265751 DOI: 10.1097/GIM.0b013e31818fd762] [Cited by in Crossref: 179] [Cited by in F6Publishing: 108] [Article Influence: 14.9] [Reference Citation Analysis]
162 Murugan S, Zhang C, Mojtahedzadeh S, Sarkar DK. Alcohol exposure in utero increases susceptibility to prostate tumorigenesis in rat offspring. Alcohol Clin Exp Res 2013;37:1901-9. [PMID: 23889735 DOI: 10.1111/acer.12171] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
163 Chiang GG, Abraham RT. Targeting the mTOR signaling network in cancer. Trends Mol Med 2007;13:433-42. [PMID: 17905659 DOI: 10.1016/j.molmed.2007.08.001] [Cited by in Crossref: 230] [Cited by in F6Publishing: 227] [Article Influence: 16.4] [Reference Citation Analysis]
164 Gupta A, Leslie NR. Controlling PTEN (Phosphatase and Tensin Homolog) Stability: A DOMINANT ROLE FOR LYSINE 66. J Biol Chem 2016;291:18465-73. [PMID: 27405757 DOI: 10.1074/jbc.M116.727750] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
165 Mester JL, Ghosh R, Pesaran T, Huether R, Karam R, Hruska KS, Costa HA, Lachlan K, Ngeow J, Barnholtz-Sloan J, Sesock K, Hernandez F, Zhang L, Milko L, Plon SE, Hegde M, Eng C. Gene-specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel. Hum Mutat 2018;39:1581-92. [PMID: 30311380 DOI: 10.1002/humu.23636] [Cited by in Crossref: 70] [Cited by in F6Publishing: 45] [Article Influence: 35.0] [Reference Citation Analysis]
166 Ng EK, Shin VY, Leung CP, Chan VW, Law FB, Siu MT, Lang BH, Ma ES, Kwong A. Elevation of methylated DNA in KILLIN/PTEN in the plasma of patients with thyroid and/or breast cancer. Onco Targets Ther 2014;7:2085-92. [PMID: 25419146 DOI: 10.2147/OTT.S53597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
167 Bader AG, Kang S, Zhao L, Vogt PK. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 2005;5:921-9. [DOI: 10.1038/nrc1753] [Cited by in Crossref: 517] [Cited by in F6Publishing: 496] [Article Influence: 32.3] [Reference Citation Analysis]
168 Li B, Krishnan VG, Mort ME, Xin F, Kamati KK, Cooper DN, Mooney SD, Radivojac P. Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics 2009;25:2744-50. [PMID: 19734154 DOI: 10.1093/bioinformatics/btp528] [Cited by in Crossref: 548] [Cited by in F6Publishing: 497] [Article Influence: 45.7] [Reference Citation Analysis]
169 Stornetta RL, Zhu JJ. Ras and Rap signaling in synaptic plasticity and mental disorders. Neuroscientist 2011;17:54-78. [PMID: 20431046 DOI: 10.1177/1073858410365562] [Cited by in Crossref: 80] [Cited by in F6Publishing: 94] [Article Influence: 7.3] [Reference Citation Analysis]
170 Winship IM, Dudding TE. Lessons from the skin--cutaneous features of familial cancer. Lancet Oncol 2008;9:462-72. [PMID: 18452857 DOI: 10.1016/S1470-2045(08)70126-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
171 Menko FH, Kneepkens CM, de Leeuw N, Peeters EA, Van Maldergem L, Kamsteeg EJ, Davidson R, Rozendaal L, Lasham CA, Peeters-Scholte CM. Variable phenotypes associated with 10q23 microdeletions involving the PTEN and BMPR1A genes. Clin Genet. 2008;74:145-154. [PMID: 18510548 DOI: 10.1111/j.1399-0004.2008.01026.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
172 Das F, Ghosh-Choudhury N, Dey N, Mandal CC, Mahimainathan L, Kasinath BS, Abboud HE, Choudhury GG. Unrestrained mammalian target of rapamycin complexes 1 and 2 increase expression of phosphatase and tensin homolog deleted on chromosome 10 to regulate phosphorylation of Akt kinase. J Biol Chem 2012;287:3808-22. [PMID: 22184110 DOI: 10.1074/jbc.M111.246397] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
173 Montebugnoli L, Felicetti L, Cervellati F, Foschini MP. Glycogenic acanthosis presenting as leukoplakia on the tongue. BMJ Case Rep 2010;2010:bcr0120102634. [PMID: 22778105 DOI: 10.1136/bcr.01.2010.2634] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
174 Ljungberg MC, Sunnen CN, Lugo JN, Anderson AE, D'Arcangelo G. Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia. Dis Model Mech 2009;2:389-98. [PMID: 19470613 DOI: 10.1242/dmm.002386] [Cited by in Crossref: 117] [Cited by in F6Publishing: 116] [Article Influence: 9.8] [Reference Citation Analysis]
175 Cho MY, Kim HS, Eng C, Kim DS, Kang SJ, Eom M, Yi SY, Bronner MP. First report of ovarian dysgerminoma in Cowden syndrome with germline PTEN mutation and PTEN-related 10q loss of tumor heterozygosity. Am J Surg Pathol 2008;32:1258-64. [PMID: 18594467 DOI: 10.1097/PAS.0b013e31816be8b7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
176 Mirzaa G, Timms AE, Conti V, Boyle EA, Girisha KM, Martin B, Kircher M, Olds C, Juusola J, Collins S, Park K, Carter M, Glass I, Krägeloh-Mann I, Chitayat D, Parikh AS, Bradshaw R, Torti E, Braddock S, Burke L, Ghedia S, Stephan M, Stewart F, Prasad C, Napier M, Saitta S, Straussberg R, Gabbett M, O'Connor BC, Keegan CE, Yin LJ, Lai AHM, Martin N, McKinnon M, Addor MC, Boccuto L, Schwartz CE, Lanoel A, Conway RL, Devriendt K, Tatton-Brown K, Pierpont ME, Painter M, Worgan L, Reggin J, Hennekam R, Tsuchiya K, Pritchard CC, Aracena M, Gripp KW, Cordisco M, Van Esch H, Garavelli L, Curry C, Goriely A, Kayserilli H, Shendure J, Graham J Jr, Guerrini R, Dobyns WB. PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution. JCI Insight 2016;1:87623. [PMID: 27631024 DOI: 10.1172/jci.insight.87623] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 24.7] [Reference Citation Analysis]
177 Planchon SM, Waite KA, Eng C. The nuclear affairs of PTEN. J Cell Sci. 2008;121:249-253. [PMID: 18216329 DOI: 10.1242/jcs.022459] [Cited by in Crossref: 193] [Cited by in F6Publishing: 193] [Article Influence: 14.8] [Reference Citation Analysis]
178 Lasky JL, Liau LM. Targeting Stem Cells in Brain Tumors. Technol Cancer Res Treat 2006;5:251-60. [DOI: 10.1177/153303460600500312] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
179 Vorstman JAS, Spooren W, Persico AM, Collier DA, Aigner S, Jagasia R, Glennon JC, Buitelaar JK. Using genetic findings in autism for the development of new pharmaceutical compounds. Psychopharmacology 2014;231:1063-78. [DOI: 10.1007/s00213-013-3334-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
180 Lee JH, Shin SY, Kim S, Choo J, Lee YH. Suppression of PTEN expression during aggregation with retinoic acid in P19 mouse embryonal carcinoma cells. Biochem Biophys Res Commun 2006;347:715-22. [PMID: 16842746 DOI: 10.1016/j.bbrc.2006.06.161] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
181 Amiri A, Cho W, Zhou J, Birnbaum SG, Sinton CM, McKay RM, Parada LF. Pten deletion in adult hippocampal neural stem/progenitor cells causes cellular abnormalities and alters neurogenesis. J Neurosci 2012;32:5880-90. [PMID: 22539849 DOI: 10.1523/JNEUROSCI.5462-11.2012] [Cited by in Crossref: 118] [Cited by in F6Publishing: 78] [Article Influence: 13.1] [Reference Citation Analysis]
182 Happle R. The group of epidermal nevus syndromes Part I. Well defined phenotypes. J Am Acad Dermatol 2010;63:1-22; quiz 23-4. [PMID: 20542174 DOI: 10.1016/j.jaad.2010.01.017] [Cited by in Crossref: 146] [Cited by in F6Publishing: 96] [Article Influence: 13.3] [Reference Citation Analysis]
183 Lin JE, Li P, Snook AE, Schulz S, Dasgupta A, Hyslop TM, Gibbons AV, Marszlowicz G, Pitari GM, Waldman SA. The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling. Gastroenterology. 2010;138:241-254. [PMID: 19737566 DOI: 10.1053/j.gastro.2009.08.064] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 6.3] [Reference Citation Analysis]
184 Griff JR, Duffy KA, Kalish JM. Characterization and Childhood Tumor Risk Assessment of Genetic and Epigenetic Syndromes Associated With Lateralized Overgrowth. Front Pediatr 2020;8:613260. [PMID: 33392121 DOI: 10.3389/fped.2020.613260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
185 Tunca B, Bekar A, Cecener G, Egeli U, Vatan O, Tolunay S, Kocaeli H, Aksoy K. Impact of novel PTEN mutations in Turkish patients with glioblastoma multiforme. J Neurooncol 2007;82:263-9. [PMID: 17151929 DOI: 10.1007/s11060-006-9293-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
186 Kolasa I, Rembiszewska A, Janiec-jankowska A, Dansonka-mieszkowska A, Lewandowska A, Konopka B, Kupryjańczyk J. PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations. Gynecologic Oncology 2006;103:692-7. [DOI: 10.1016/j.ygyno.2006.05.007] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
187 Sharabi SE, Koshy JC, Hollier LH Jr. Multiple, recurrent, refractory vascular malformations as the primary presenting feature of a PTEN mutation. Pediatr Dermatol 2011;28:466-7. [PMID: 21793891 DOI: 10.1111/j.1525-1470.2010.01298.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
188 Busa T, Chabrol B, Perret O, Longy M, Philip N. Novel PTEN germline mutation in a family with mild phenotype: Difficulties in genetic counseling. Gene 2013;512:194-7. [DOI: 10.1016/j.gene.2012.09.134] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
189 D'Angelo ND, Kim TS, Andrews K, Booker SK, Caenepeel S, Chen K, D'Amico D, Freeman D, Jiang J, Liu L, McCarter JD, San Miguel T, Mullady EL, Schrag M, Subramanian R, Tang J, Wahl RC, Wang L, Whittington DA, Wu T, Xi N, Xu Y, Yakowec P, Yang K, Zalameda LP, Zhang N, Hughes P, Norman MH. Discovery and optimization of a series of benzothiazole phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors. J Med Chem 2011;54:1789-811. [PMID: 21332118 DOI: 10.1021/jm1014605] [Cited by in Crossref: 78] [Cited by in F6Publishing: 65] [Article Influence: 7.8] [Reference Citation Analysis]
190 Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell. 2007;12:9-22. [PMID: 17613433 DOI: 10.1016/j.ccr.2007.05.008] [Cited by in Crossref: 2011] [Cited by in F6Publishing: 1945] [Article Influence: 143.6] [Reference Citation Analysis]
191 Jacob AI, Romigh T, Waite KA, Eng C. Nuclear PTEN levels and G2 progression in melanoma cells. Melanoma Res 2009;19:203-10. [PMID: 19478684 DOI: 10.1097/CMR.0b013e32832ccd6e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
192 Ngeow J, Sesock K, Eng C. Breast cancer risk and clinical implications for germline PTEN mutation carriers. Breast Cancer Res Treat 2017;165:1-8. [DOI: 10.1007/s10549-015-3665-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
193 He S, Lin J, Yu S, Sun S. Upregulation of PREX2 promotes the proliferation and migration of hepatocellular carcinoma cells via PTEN-AKT signaling. Oncol Lett 2016;11:2223-8. [PMID: 26998152 DOI: 10.3892/ol.2016.4164] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
194 Salmena L, Pandolfi PP. Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation. Nat Rev Cancer 2007;7:409-13. [PMID: 17508027 DOI: 10.1038/nrc2145] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 4.1] [Reference Citation Analysis]
195 Han X, Ji Y, Zhao J, Xu X, Lou W. Expression of PTEN and mTOR in pancreatic neuroendocrine tumors. Tumor Biol 2013;34:2871-9. [DOI: 10.1007/s13277-013-0849-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
196 Ngeow J, Mester J, Rybicki LA, Ni Y, Milas M, Eng C. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations. J Clin Endocrinol Metab. 2011;96:E2063-E2071. [PMID: 21956414 DOI: 10.1210/jc.2011-1616] [Cited by in Crossref: 116] [Cited by in F6Publishing: 92] [Article Influence: 11.6] [Reference Citation Analysis]
197 Sun Z, Lu J, Wu M, Ouyang C, Xing Y, Hou X, Shi Z, Wu Y. PTEN-knockdown disrupts the morphology, growth pattern and function of Nthy-Ori 3-1 cells by downregulating PAX8 expression. Oncol Lett 2019;18:6732-40. [PMID: 31807182 DOI: 10.3892/ol.2019.11028] [Reference Citation Analysis]
198 Souza PVSD, Pinto WBVDR, Santos AJ. Metastatic breast cancer in a man with nonprogressive ataxia and epilepsy. Neurology 2015;85:1183-4. [DOI: 10.1212/wnl.0000000000001977] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
199 Gustafson S, Zbuk KM, Scacheri C, Eng C. Cowden syndrome. Semin Oncol 2007;34:428-34. [PMID: 17920899 DOI: 10.1053/j.seminoncol.2007.07.009] [Cited by in Crossref: 102] [Cited by in F6Publishing: 71] [Article Influence: 7.3] [Reference Citation Analysis]
200 Schmid AC, Byrne RD, Vilar R, Woscholski R. Bisperoxovanadium compounds are potent PTEN inhibitors. FEBS Lett 2004;566:35-8. [PMID: 15147864 DOI: 10.1016/j.febslet.2004.03.102] [Cited by in Crossref: 158] [Cited by in F6Publishing: 165] [Article Influence: 9.3] [Reference Citation Analysis]
201 Zhang R, Banik NL, Ray SK. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis. Neurochem Res. 2007;32:2194-2202. [PMID: 17616812 DOI: 10.1007/s11064-007-9417-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
202 Lobo GP, Waite KA, Planchon SM, Romigh T, Houghton JA, Eng C. ATP modulates PTEN subcellular localization in multiple cancer cell lines. Human Molecular Genetics 2008;17:2877-85. [DOI: 10.1093/hmg/ddn185] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
203 Sotos JF, Argente J. Overgrowth disorders associated with tall stature. Adv Pediatr 2008;55:213-54. [PMID: 19048732 DOI: 10.1016/j.yapd.2008.07.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
204 Wang Y, Romigh T, He X, Tan M, Orloff MS, Silverman RH, Heston WD, Eng C. Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers. Oncogene 2011;30:4327-38. [DOI: 10.1038/onc.2011.144] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 6.3] [Reference Citation Analysis]
205 Fraser MM, Bayazitov IT, Zakharenko SS, Baker SJ. Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities. Neuroscience 2008;151:476-88. [PMID: 18082964 DOI: 10.1016/j.neuroscience.2007.10.048] [Cited by in Crossref: 120] [Cited by in F6Publishing: 128] [Article Influence: 8.6] [Reference Citation Analysis]
206 Levine MN, Raines RT. Sensitive fluorogenic substrate for alkaline phosphatase. Anal Biochem 2011;418:247-52. [PMID: 21827735 DOI: 10.1016/j.ab.2011.07.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
207 Tian T, Nan K, Wang S, Liang X, Lu C, Guo H, Wang W, Ruan Z. PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells. Carcinogenesis 2010;31:1211-9. [DOI: 10.1093/carcin/bgq085] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
208 Rodrigues MS, Reddy MM, Sattler M. Cell cycle regulation by oncogenic tyrosine kinases in myeloid neoplasias: from molecular redox mechanisms to health implications. Antioxid Redox Signal 2008;10:1813-48. [PMID: 18593226 DOI: 10.1089/ars.2008.2071] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
209 Ngeow J, Eng C. PTEN in Hereditary and Sporadic Cancer. Cold Spring Harb Perspect Med 2020;10:a036087. [PMID: 31570378 DOI: 10.1101/cshperspect.a036087] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
210 Dotto J, Nosé V. Familial thyroid carcinoma: a diagnostic algorithm. Adv Anat Pathol 2008;15:332-49. [PMID: 18948764 DOI: 10.1097/PAP.0b013e31818a64af] [Cited by in Crossref: 46] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
211 Bignold LP. The cell-type-specificity of inherited predispositions to tumours: review and hypothesis. Cancer Lett. 2004;216:127-146. [PMID: 15533589 DOI: 10.1016/j.canlet.2004.07.037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
212 Sarquis MS, Agrawal S, Shen L, Pilarski R, Zhou XP, Eng C. Distinct expression profiles for PTEN transcript and its splice variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. Am J Hum Genet 2006;79:23-30. [PMID: 16773562 DOI: 10.1086/504392] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
213 Kalailingam P, Tan HB, Pan JY, Tan SH, Thanabalu T. Overexpression of CDC42SE1 in A431 Cells Reduced Cell Proliferation by Inhibiting the Akt Pathway. Cells 2019;8:E117. [PMID: 30717410 DOI: 10.3390/cells8020117] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
214 Eng C, Weber F. Gene-expression profiling in differentiated thyroid cancer – a viable strategy for the practice of genomic medicine? Future Oncology 2005;1:497-510. [DOI: 10.2217/14796694.1.4.497] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
215 McCrea HJ, De Camilli P. Mutations in phosphoinositide metabolizing enzymes and human disease. Physiology (Bethesda) 2009;24:8-16. [PMID: 19196647 DOI: 10.1152/physiol.00035.2008] [Cited by in Crossref: 114] [Cited by in F6Publishing: 123] [Article Influence: 9.5] [Reference Citation Analysis]
216 Lacey JV Jr, Mutter GL, Ronnett BM, Ioffe OB, Duggan MA, Rush BB, Glass AG, Richesson DA, Chatterjee N, Langholz B, Sherman ME. PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma. Cancer Res 2008;68:6014-20. [PMID: 18632658 DOI: 10.1158/0008-5472.CAN-08-1154] [Cited by in Crossref: 53] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
217 Iwanaga K, Yang Y, Raso MG, Ma L, Hanna AE, Thilaganathan N, Moghaddam S, Evans CM, Li H, Cai WW. Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer. Cancer Res. 2008;68:1119-1127. [PMID: 18281487 DOI: 10.1158/0008-5472.can-07-3117] [Cited by in Crossref: 86] [Cited by in F6Publishing: 59] [Article Influence: 6.6] [Reference Citation Analysis]
218 Mathew G, Hannan A, Hertzler-Schaefer K, Wang F, Feng GS, Zhong J, Zhao JJ, Downward J, Zhang X. Targeting of Ras-mediated FGF signaling suppresses Pten-deficient skin tumor. Proc Natl Acad Sci U S A 2016;113:13156-61. [PMID: 27799550 DOI: 10.1073/pnas.1604450113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
219 Ciaccio C, Saletti V, D'Arrigo S, Esposito S, Alfei E, Moroni I, Tonduti D, Chiapparini L, Pantaleoni C, Milani D. Clinical spectrum of PTEN mutation in pediatric patients. A bicenter experience. Eur J Med Genet 2019;62:103596. [PMID: 30528446 DOI: 10.1016/j.ejmg.2018.12.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
220 Noguchi M, Hirata N, Tanaka T, Suizu F, Nakajima H, Chiorini JA. Autophagy as a modulator of cell death machinery. Cell Death Dis 2020;11:517. [PMID: 32641772 DOI: 10.1038/s41419-020-2724-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 24.0] [Reference Citation Analysis]
221 Newton AC. Protein kinase C as a tumor suppressor. Semin Cancer Biol 2018;48:18-26. [PMID: 28476658 DOI: 10.1016/j.semcancer.2017.04.017] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
222 Abdo JF, Sharma A, Sharma R. Role of Heredity in Melanoma Susceptibility: A Primer for the Practicing Surgeon. Surg Clin North Am 2020;100:13-28. [PMID: 31753108 DOI: 10.1016/j.suc.2019.09.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
223 Zhao L, Vogt PK. Class I PI3K in oncogenic cellular transformation. Oncogene. 2008;27:5486-5496. [PMID: 18794883 DOI: 10.1038/onc.2008.244] [Cited by in Crossref: 390] [Cited by in F6Publishing: 372] [Article Influence: 30.0] [Reference Citation Analysis]
224 Dahdaleh FS, Carr JC, Calva D, Howe JR. Juvenile polyposis and other intestinal polyposis syndromes with microdeletions of chromosome 10q22-23. Clin Genet. 2012;81:110-116. [PMID: 21834858 DOI: 10.1111/j.1399-0004.2011.01763.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
225 He X, Arrotta N, Radhakrishnan D, Wang Y, Romigh T, Eng C. Cowden syndrome-related mutations in PTEN associate with enhanced proteasome activity. Cancer Res 2013;73:3029-40. [PMID: 23475934 DOI: 10.1158/0008-5472.CAN-12-3811] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
226 Gatti G, Mazzarol G, Simsek S, Viale G. Breast hamartoma: a case report. Breast Cancer Res Treat 2005;89:145-7. [DOI: 10.1007/s10549-004-1656-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
227 Alvarez-Breckenridge CA, Waite KA, Eng C. PTEN regulates phospholipase D and phospholipase C. Hum Mol Genet. 2007;16:1157-1163. [PMID: 17405772 DOI: 10.1093/hmg/ddm063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
228 Corradetti MN, Guan K. Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 2006;25:6347-60. [DOI: 10.1038/sj.onc.1209885] [Cited by in Crossref: 284] [Cited by in F6Publishing: 272] [Article Influence: 18.9] [Reference Citation Analysis]
229 McDermott SP, Wicha MS. Targeting breast cancer stem cells. Mol Oncol. 2010;4:404-419. [PMID: 20599450 DOI: 10.1016/j.molonc.2010.06.005] [Cited by in Crossref: 139] [Cited by in F6Publishing: 141] [Article Influence: 12.6] [Reference Citation Analysis]
230 Buxbaum JD, Cai G, Chaste P, Nygren G, Goldsmith J, Reichert J, Anckarsäter H, Rastam M, Smith CJ, Silverman JM, Hollander E, Leboyer M, Gillberg C, Verloes A, Betancur C. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B Neuropsychiatr Genet 2007;144B:484-91. [PMID: 17427195 DOI: 10.1002/ajmg.b.30493] [Cited by in Crossref: 186] [Cited by in F6Publishing: 172] [Article Influence: 13.3] [Reference Citation Analysis]
231 Naughton R, Quiney C, Turner SD, Cotter TG. Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway. Leukemia 2009;23:1432-40. [DOI: 10.1038/leu.2009.49] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 8.4] [Reference Citation Analysis]
232 De Rosa M, Pace U, Rega D, Costabile V, Duraturo F, Izzo P, Delrio P. Genetics, diagnosis and management of colorectal cancer (Review). Oncol Rep. 2015;34:1087-1096. [PMID: 26151224 DOI: 10.3892/or.2015.4108] [Cited by in Crossref: 141] [Cited by in F6Publishing: 143] [Article Influence: 23.5] [Reference Citation Analysis]
233 Agrawal S, Eng C. Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer. Human Molecular Genetics 2006;15:777-87. [DOI: 10.1093/hmg/ddi492] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
234 Septer S, Zhang L, Lawson CE, Cocjin J, Attard T, Ardinger HH. Aggressive juvenile polyposis in children with chromosome 10q23 deletion. World J Gastroenterol 2013; 19(14): 2286-2292 [PMID: 23599658 DOI: 10.3748/wjg.v19.i14.2286] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
235 Ueno Y, Enokizono T, Fukushima H, Ohto T, Imagawa K, Tanaka M, Sakai A, Suzuki H, Uehara T, Takenouchi T, Kosaki K, Takada H. A novel missense PTEN mutation identified in a patient with macrocephaly and developmental delay. Hum Genome Var 2019;6:25. [PMID: 31149344 DOI: 10.1038/s41439-019-0056-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
236 de Assis LV, Locatelli J, Isoldi MC. The role of key genes and pathways involved in the tumorigenesis of Malignant Mesothelioma. Biochim Biophys Acta 2014;1845:232-47. [PMID: 24491449 DOI: 10.1016/j.bbcan.2014.01.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
237 Calonje E, Brenn T, Lazar A. Tumors of the hair follicle. McKee's Pathology of the Skin. Elsevier; 2012. pp. 1445-87. [DOI: 10.1016/b978-1-4160-5649-2.00031-7] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
238 Rodríguez-Escudero I, Oliver MD, Andrés-Pons A, Molina M, Cid VJ, Pulido R. A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes. Hum Mol Genet. 2011;20:4132-4142. [PMID: 21828076 DOI: 10.1093/hmg/ddr337] [Cited by in Crossref: 125] [Cited by in F6Publishing: 118] [Article Influence: 12.5] [Reference Citation Analysis]
239 Gunaratne J, Goh MX, Swa HL, Lee FY, Sanford E, Wong LM, Hogue KA, Blackstock WP, Okumura K. Protein interactions of phosphatase and tensin homologue (PTEN) and its cancer-associated G20E mutant compared by using stable isotope labeling by amino acids in cell culture-based parallel affinity purification. J Biol Chem 2011;286:18093-103. [PMID: 21454687 DOI: 10.1074/jbc.M111.221184] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
240 Beckham TH, Cheng JC, Marrison ST, Norris JS, Liu X. Interdiction of sphingolipid metabolism to improve standard cancer therapies. Adv Cancer Res. 2013;117:1-36. [PMID: 23290775 DOI: 10.1016/b978-0-12-394274-6.00001-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
241 Aradhya S, Lewis R, Bonaga T, Nwokekeh N, Stafford A, Boggs B, Hruska K, Smaoui N, Compton JG, Richard G. Exon-level array CGH in a large clinical cohort demonstrates increased sensitivity of diagnostic testing for Mendelian disorders. Genet Med. 2012;14:594-603. [PMID: 22382802 DOI: 10.1038/gim.2011.65] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
242 Chung S, Nakashima M, Zembutsu H, Nakamura Y. Possible involvement of NEDD4 in keloid formation; its critical role in fibroblast proliferation and collagen production. Proc Jpn Acad Ser B Phys Biol Sci 2011;87:563-73. [PMID: 21986318 DOI: 10.2183/pjab.87.563] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
243 Hu Z, Wang Y, Huang F, Chen R, Li C, Wang F, Goto J, Kwiatkowski DJ, Wdzieczak-Bakala J, Tu P, Liu J, Zha X, Zhang H. Brain-expressed X-linked 2 Is Pivotal for Hyperactive Mechanistic Target of Rapamycin (mTOR)-mediated Tumorigenesis. J Biol Chem 2015;290:25756-65. [PMID: 26296882 DOI: 10.1074/jbc.M115.665208] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
244 Ma J, Sawai H, Matsuo Y, Ochi N, Yasuda A, Takahashi H, Wakasugi T, Funahashi H, Sato M, Takeyama H. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells. J Surg Res. 2010;160:90-101. [PMID: 19560785 DOI: 10.1016/j.jss.2008.08.016] [Cited by in Crossref: 79] [Cited by in F6Publishing: 78] [Article Influence: 6.1] [Reference Citation Analysis]
245 Okumura N, Yoshida H, Kitagishi Y, Nishimura Y, Matsuda S. Alternative splicings on p53, BRCA1 and PTEN genes involved in breast cancer. Biochemical and Biophysical Research Communications 2011;413:395-9. [DOI: 10.1016/j.bbrc.2011.08.098] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
246 Smith IN, Thacker S, Jaini R, Eng C. Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes. J Biomol Struct Dyn 2019;37:1766-82. [PMID: 29663862 DOI: 10.1080/07391102.2018.1465854] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
247 Teresi RE, Zbuk KM, Pezzolesi MG, Waite KA, Eng C. Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation. Am J Hum Genet. 2007;81:756-767. [PMID: 17847000 DOI: 10.1086/521051] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 4.1] [Reference Citation Analysis]
248 Baba M, Furihata M, Hong SB, Tessarollo L, Haines DC, Southon E, Patel V, Igarashi P, Alvord WG, Leighty R, Yao M, Bernardo M, Ileva L, Choyke P, Warren MB, Zbar B, Linehan WM, Schmidt LS. Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J Natl Cancer Inst 2008;100:140-54. [PMID: 18182616 DOI: 10.1093/jnci/djm288] [Cited by in Crossref: 176] [Cited by in F6Publishing: 155] [Article Influence: 13.5] [Reference Citation Analysis]
249 Altomare DA, Testa JR. Perturbations of the AKT signaling pathway in human cancer. Oncogene 2005;24:7455-64. [PMID: 16288292 DOI: 10.1038/sj.onc.1209085] [Cited by in Crossref: 896] [Cited by in F6Publishing: 857] [Article Influence: 56.0] [Reference Citation Analysis]
250 Leslie NR, Downes CP. PTEN function: how normal cells control it and tumour cells lose it. Biochem J 2004;382:1-11. [PMID: 15193142 DOI: 10.1042/BJ20040825] [Cited by in Crossref: 305] [Cited by in F6Publishing: 138] [Article Influence: 19.1] [Reference Citation Analysis]
251 Liu J, Ding G, Zou K, Jiang Z, Zhang J, Lu Y, Pignata A, Venner E, Liu P, Liu Z, Wangler MF, Sun Z. Genome sequencing analysis of a family with a child displaying severe abdominal distention and recurrent hypoglycemia. Mol Genet Genomic Med 2020;8:e1130. [PMID: 31971667 DOI: 10.1002/mgg3.1130] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
252 Umemura K, Takagi S, Ishigaki Y, Iwabuchi M, Kuroki S, Kinouchi Y, Shimosegawa T. Gastrointestinal polyposis with esophageal polyposis is useful for early diagnosis of Cowden’s disease. World J Gastroenterol 2008; 14(37): 5755-5759 [PMID: 18837096 DOI: 10.3748/wjg.14.5755] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
253 Schubert SA, Morreau H, de Miranda NFCC, van Wezel T. The missing heritability of familial colorectal cancer. Mutagenesis 2020;35:221-31. [PMID: 31605533 DOI: 10.1093/mutage/gez027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
254 Piccinin C, Panchal S, Watkins N, Kim RH. An update on genetic risk assessment and prevention: the role of genetic testing panels in breast cancer. Expert Rev Anticancer Ther 2019;19:787-801. [PMID: 31469018 DOI: 10.1080/14737140.2019.1659730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
255 Hemminki K, Chen B. Familial risks for colorectal cancer show evidence on recessive inheritance. Int J Cancer 2005;115:835-8. [DOI: 10.1002/ijc.20938] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
256 Frazier TW, Jaini R, Busch RM, Wolf M, Sadler T, Klaas P, Hardan AY, Martinez-Agosto JA, Sahin M, Eng C; Developmental Synaptopathies Consortium. Cross-level analysis of molecular and neurobehavioral function in a prospective series of patients with germline heterozygous PTEN mutations with and without autism. Mol Autism 2021;12:5. [PMID: 33509259 DOI: 10.1186/s13229-020-00406-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
257 Eldon BJ, Thorlacius S, Jonsson T, Jonasson JG, Kjartansson J, Bodvarsson S, Steingrimsson E, Rafnar T. A population-based study on the familial aggregation of cutaneous malignant melanoma in Iceland. European Journal of Cancer 2006;42:922-6. [DOI: 10.1016/j.ejca.2005.11.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
258 Hansen-kiss E, Beinkampen S, Adler B, Frazier T, Prior T, Erdman S, Eng C, Herman G. A retrospective chart review of the features of PTEN hamartoma tumour syndrome in children. J Med Genet 2017;54:471-8. [DOI: 10.1136/jmedgenet-2016-104484] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 12.0] [Reference Citation Analysis]
259 Jin G, Kim MJ, Jeon HS, Choi JE, Kim DS, Lee EB, Cha SI, Yoon GS, Kim CH, Jung TH, Park JY. PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers. Lung Cancer 2010;69:279-83. [PMID: 20018398 DOI: 10.1016/j.lungcan.2009.11.012] [Cited by in Crossref: 116] [Cited by in F6Publishing: 121] [Article Influence: 9.7] [Reference Citation Analysis]
260 Bellacosa A, Kumar CC, Di Cristofano A, Testa JR. Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res. 2005;94:29-86. [PMID: 16095999 DOI: 10.1016/s0065-230x(05)94002-5] [Cited by in Crossref: 526] [Cited by in F6Publishing: 285] [Article Influence: 32.9] [Reference Citation Analysis]
261 Valnegri P, Sala C, Passafaro M. Synaptic dysfunction and intellectual disability. Adv Exp Med Biol 2012;970:433-49. [PMID: 22351067 DOI: 10.1007/978-3-7091-0932-8_19] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
262 Hobert JA, Eng C. PTEN hamartoma tumor syndrome: An overview. Genet Med 2009;11:687-94. [DOI: 10.1097/gim.0b013e3181ac9aea] [Cited by in Crossref: 220] [Cited by in F6Publishing: 94] [Article Influence: 18.3] [Reference Citation Analysis]
263 Haddadi N, Lin Y, Travis G, Simpson AM, Nassif NT, McGowan EM. PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy. Mol Cancer 2018;17:37. [PMID: 29455665 DOI: 10.1186/s12943-018-0803-3] [Cited by in Crossref: 73] [Cited by in F6Publishing: 78] [Article Influence: 24.3] [Reference Citation Analysis]
264 Bauer AJ, Stratakis CA. The lentiginoses: cutaneous markers of systemic disease and a window to new aspects of tumourigenesis. J Med Genet 2005;42:801-10. [PMID: 15958502 DOI: 10.1136/jmg.2003.017806] [Cited by in Crossref: 43] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
265 Fouladkou F, Landry T, Kawabe H, Neeb A, Lu C, Brose N, Stambolic V, Rotin D. The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization. Proc Natl Acad Sci USA. 2008;105:8585-8590. [PMID: 18562292 DOI: 10.1073/pnas.0803233105] [Cited by in Crossref: 123] [Cited by in F6Publishing: 125] [Article Influence: 9.5] [Reference Citation Analysis]
266 Govatati S, Kodati VL, Deenadayal M, Chakravarty B, Shivaji S, Bhanoori M. Mutations in the PTEN tumor gene and risk of endometriosis: a case-control study. Hum Reprod 2014;29:324-36. [PMID: 24154570 DOI: 10.1093/humrep/det387] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
267 Mak BC, Yeung RS. The Tuberous Sclerosis Complex Genes in Tumor Development. Cancer Investigation 2004;22:588-603. [DOI: 10.1081/cnv-200027144] [Cited by in Crossref: 64] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
268 Mak BC, Kenerson HL, Aicher LD, Barnes EA, Yeung RS. Aberrant beta-catenin signaling in tuberous sclerosis. Am J Pathol 2005;167:107-16. [PMID: 15972957 DOI: 10.1016/s0002-9440(10)62958-6] [Cited by in Crossref: 62] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
269 Liu D, Yang Z. Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma. Pathology - Research and Practice 2011;207:472-8. [DOI: 10.1016/j.prp.2011.05.010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
270 Zhan MN, Yu XT, Tang J, Zhou CX, Wang CL, Yin QQ, Gong XF, He M, He JR, Chen GQ, Zhao Q. MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1. Cell Death Dis 2017;8:e2529. [PMID: 28055013 DOI: 10.1038/cddis.2016.440] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 12.8] [Reference Citation Analysis]
271 Li P, Wang D, Li H, Yu Z, Chen X, Fang J. Identification of nucleolus-localized PTEN and its function in regulating ribosome biogenesis. Mol Biol Rep 2014;41:6383-90. [DOI: 10.1007/s11033-014-3518-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
272 Holt AE 3rd, Ferguson BL, Gibson TM, Satheesh KM, Cobb CM. Phosphatase and Tensin Homolog Hamartoma Tumor Syndrome: A Case Report. Clin Adv Periodontics 2016;6:21-6. [PMID: 32689721 DOI: 10.1902/cap.2015.140095] [Reference Citation Analysis]
273 Jin M, Hampel H, Pilarski R, Zhou X, Peters S, Frankel WL. Phosphatase and tensin homolog immunohistochemical staining and clinical criteria for Cowden syndrome in patients with trichilemmoma or associated lesions. Am J Dermatopathol 2013;35:637-40. [PMID: 23715080 DOI: 10.1097/DAD.0b013e31827e28f7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
274 Odriozola L, Singh G, Hoang T, Chan AM. Regulation of PTEN Activity by Its Carboxyl-terminal Autoinhibitory Domain. Journal of Biological Chemistry 2007;282:23306-15. [DOI: 10.1074/jbc.m611240200] [Cited by in Crossref: 126] [Cited by in F6Publishing: 76] [Article Influence: 9.0] [Reference Citation Analysis]
275 Bilanges B, Stokoe D. Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene 2007;26:5973-90. [PMID: 17404576 DOI: 10.1038/sj.onc.1210431] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 4.4] [Reference Citation Analysis]
276 Dhamija R, Weindling SM, Porter AB, Hu LS, Wood CP, Hoxworth JM. Neuroimaging abnormalities in patients with Cowden syndrome: Retrospective single-center study. Neurol Clin Pract 2018;8:207-13. [PMID: 30105160 DOI: 10.1212/CPJ.0000000000000463] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
277 Rodríguez-Escudero I, Roelants FM, Thorner J, Nombela C, Molina M, Cid VJ. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast. Biochem J 2005;390:613-23. [PMID: 15913452 DOI: 10.1042/BJ20050574] [Cited by in Crossref: 70] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
278 Won HS, Chang ED, Na SJ, Whang IY, Lee DS, You SH, Kim YS, Kim JS. PTEN Mutation Identified in Patient Diagnosed with Simultaneous Multiple Cancers. Cancer Res Treat 2019;51:402-7. [PMID: 29510612 DOI: 10.4143/crt.2017.579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
279 Li W, Zhu T, Guan KL. Transformation potential of Ras isoforms correlates with activation of phosphatidylinositol 3-kinase but not ERK. J Biol Chem 2004;279:37398-406. [PMID: 15210703 DOI: 10.1074/jbc.M405730200] [Cited by in Crossref: 60] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
280 Rinaldo L, Lanzino G, Flemming KD, Krings T, Brinjikji W. Symptomatic developmental venous anomalies. Acta Neurochir (Wien) 2020;162:1115-25. [PMID: 31925540 DOI: 10.1007/s00701-020-04213-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
281 Stiles BL. Phosphatase and tensin homologue deleted on chromosome 10: extending its PTENtacles. Int J Biochem Cell Biol 2009;41:757-61. [PMID: 18950730 DOI: 10.1016/j.biocel.2008.09.022] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
282 Urbanek K, Lesiak M, Krakowian D, Koryciak-Komarska H, Likus W, Czekaj P, Kusz D, Sieroń AL. Notch signaling pathway and gene expression profiles during early in vitro differentiation of liver-derived mesenchymal stromal cells to osteoblasts. Lab Invest 2017;97:1225-34. [PMID: 28805807 DOI: 10.1038/labinvest.2017.60] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
283 Lintas C, Persico AM. Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist. J Med Genet 2009;46:1-8. [PMID: 18728070 DOI: 10.1136/jmg.2008.060871] [Cited by in Crossref: 113] [Cited by in F6Publishing: 92] [Article Influence: 8.7] [Reference Citation Analysis]
284 Song CH, Yang SH, Park E, Cho SH, Gong EY, Khadka DB, Cho WJ, Lee K. Structure-based virtual screening and identification of a novel androgen receptor antagonist. J Biol Chem 2012;287:30769-80. [PMID: 22798067 DOI: 10.1074/jbc.M112.379107] [Cited by in Crossref: 27] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
285 Kim RH, Mak TW. Tumours and tremors: how PTEN regulation underlies both. Br J Cancer. 2006;94:620-624. [PMID: 16495927 DOI: 10.1038/sj.bjc.6602994] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 3.7] [Reference Citation Analysis]
286 Winter SF, Hunter KW. Mouse modifier genes in mammary tumorigenesis and metastasis. J Mammary Gland Biol Neoplasia 2008;13:337-42. [PMID: 18661105 DOI: 10.1007/s10911-008-9089-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
287 Lachlan KL, Lucassen AM, Bunyan D, Temple IK. Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet 2007;44:579-85. [PMID: 17526800 DOI: 10.1136/jmg.2007.049981] [Cited by in Crossref: 123] [Cited by in F6Publishing: 93] [Article Influence: 8.8] [Reference Citation Analysis]
288 Ngeow J, Eng C. Germline PTEN Mutation Analysis for PTEN Hamartoma Tumor Syndrome. Methods Mol Biol 2016;1388:63-73. [PMID: 27033071 DOI: 10.1007/978-1-4939-3299-3_6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
289 McCall P, Witton CJ, Grimsley S, Nielsen KV, Edwards J. Is PTEN loss associated with clinical outcome measures in human prostate cancer? Br J Cancer 2008;99:1296-301. [PMID: 18854827 DOI: 10.1038/sj.bjc.6604680] [Cited by in Crossref: 105] [Cited by in F6Publishing: 100] [Article Influence: 8.1] [Reference Citation Analysis]
290 Cheshier SH, Kalani MY, Pendakaur A, Higgins D, Kahn D, Shendel S, Shuer L. Two-year-old girl with cervicomedullary junction stenosis and an unknown type of skeletal dysplasia. J Neurosurg Pediatr 2008;2:200-2. [PMID: 18759602 DOI: 10.3171/PED/2008/2/9/200] [Reference Citation Analysis]
291 Feng C, Yao R, Huang F, Liu X, Nie W. High level of PTEN expression is associated with low-grade liver metastasis and satisfactory patient survival in pancreatic cancer. Arch Med Res 2011;42:584-8. [PMID: 22036936 DOI: 10.1016/j.arcmed.2011.10.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
292 Getz SA, DeSpenza T Jr, Li M, Luikart BW. Rapamycin prevents, but does not reverse, aberrant migration in Pten knockout neurons. Neurobiol Dis 2016;93:12-20. [PMID: 26992888 DOI: 10.1016/j.nbd.2016.03.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
293 Tell G, Pines A, Arturi F, Cesaratto L, Adamson E, Puppin C, Presta I, Russo D, Filetti S, Damante G. Control of phosphatase and tensin homolog (PTEN) gene expression in normal and neoplastic thyroid cells. Endocrinology 2004;145:4660-6. [PMID: 15231710 DOI: 10.1210/en.2004-0282] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
294 Herman GE, Butter E, Enrile B, Pastore M, Prior TW, Sommer A. Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly. Am J Med Genet A 2007;143A:589-93. [PMID: 17286265 DOI: 10.1002/ajmg.a.31619] [Cited by in Crossref: 119] [Cited by in F6Publishing: 113] [Article Influence: 8.5] [Reference Citation Analysis]
295 Kobar K, Collett K, Prykhozhij SV, Berman JN. Zebrafish Cancer Predisposition Models. Front Cell Dev Biol 2021;9:660069. [PMID: 33987182 DOI: 10.3389/fcell.2021.660069] [Reference Citation Analysis]
296 Cully M, You H, Levine AJ, Mak TW. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer. 2006;6:184-192. [PMID: 16453012 DOI: 10.1038/nrc1819] [Cited by in Crossref: 872] [Cited by in F6Publishing: 787] [Article Influence: 58.1] [Reference Citation Analysis]
297 Cooper JB, Cohen EE. Mechanisms of resistance to EGFR inhibitors in head and neck cancer. Head Neck 2009;31:1086-94. [PMID: 19378324 DOI: 10.1002/hed.21109] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
298 Gamsiz ED, Sciarra LN, Maguire AM, Pescosolido MF, van Dyck LI, Morrow EM. Discovery of Rare Mutations in Autism: Elucidating Neurodevelopmental Mechanisms. Neurotherapeutics 2015;12:553-71. [PMID: 26105128 DOI: 10.1007/s13311-015-0363-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
299 Keppler-Noreuil KM, Rios JJ, Parker VE, Semple RK, Lindhurst MJ, Sapp JC, Alomari A, Ezaki M, Dobyns W, Biesecker LG. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A 2015;167A:287-95. [PMID: 25557259 DOI: 10.1002/ajmg.a.36836] [Cited by in Crossref: 229] [Cited by in F6Publishing: 185] [Article Influence: 32.7] [Reference Citation Analysis]
300 Haws ME, Jaramillo TC, Espinosa F, Widman AJ, Stuber GD, Sparta DR, Tye KM, Russo SJ, Parada LF, Stavarache M, Kaplitt M, Bonci A, Powell CM. PTEN knockdown alters dendritic spine/protrusion morphology, not density. J Comp Neurol 2014;522:1171-90. [PMID: 24264880 DOI: 10.1002/cne.23488] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
301 Prescott KR, Wilkie AO. Genetic aspects of birth defects: new understandings of old problems. Arch Dis Child Fetal Neonatal Ed 2007;92:F308-14. [PMID: 17585097 DOI: 10.1136/adc.2004.062968] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
302 Yang Y, Iwanaga K, Raso MG, Wislez M, Hanna AE, Wieder ED, Molldrem JJ, Wistuba II, Powis G, Demayo FJ, Kim CF, Kurie JM. Phosphatidylinositol 3-kinase mediates bronchioalveolar stem cell expansion in mouse models of oncogenic K-ras-induced lung cancer. PLoS One 2008;3:e2220. [PMID: 18493606 DOI: 10.1371/journal.pone.0002220] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 4.9] [Reference Citation Analysis]
303 Hao J, Zhu L, Zhao S, Liu S, Liu Q, Duan H. PTEN ameliorates high glucose-induced lipid deposits through regulating SREBP-1/FASN/ACC pathway in renal proximal tubular cells. Exp Cell Res 2011;317:1629-39. [PMID: 21320485 DOI: 10.1016/j.yexcr.2011.02.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
304 Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol. 2009;4:127-150. [PMID: 18767981 DOI: 10.1146/annurev.pathol.4.110807.092311] [Cited by in Crossref: 723] [Cited by in F6Publishing: 702] [Article Influence: 60.3] [Reference Citation Analysis]
305 Zhu X, Qin X, Fei M, Hou W, Greshock J, Bachman KE, Wooster R, Kang J, Qin CY. Combined phosphatase and tensin homolog (PTEN) loss and fatty acid synthase (FAS) overexpression worsens the prognosis of Chinese patients with hepatocellular carcinoma. Int J Mol Sci. 2012;13:9980-9991. [PMID: 22949843 DOI: 10.3390/ijms13089980] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
306 Nahta R, Shabaya S, Ozbay T, Rowe DL. Personalizing HER2-targeted therapy in metastatic breast cancer beyond HER2 status: what we have learned from clinical specimens. Curr Pharmacogenomics Person Med 2009;7:263-74. [PMID: 20300449 DOI: 10.2174/187569209790112337] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
307 Vasovcak P, Krepelova A, Puchmajerova A, Spicak J, Voska L, Musilova A, Mestak J, Martinek J. A novel mutation of PTEN gene in a patient with Cowden syndrome with excessive papillomatosis of the lips, discrete cutaneous lesions, and gastrointestinal polyposis: . European Journal of Gastroenterology & Hepatology 2007;19:513-7. [DOI: 10.1097/meg.0b013e3280d6ed4b] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
308 Comrie WA, Lenardo MJ. Molecular Classification of Primary Immunodeficiencies of T Lymphocytes. Adv Immunol 2018;138:99-193. [PMID: 29731008 DOI: 10.1016/bs.ai.2018.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
309 Knowles MA, Platt FM, Ross RL, Hurst CD. Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer. Cancer Metastasis Rev 2009;28:305-16. [PMID: 20013032 DOI: 10.1007/s10555-009-9198-3] [Cited by in Crossref: 104] [Cited by in F6Publishing: 102] [Article Influence: 9.5] [Reference Citation Analysis]
310 Harvey RD, Lonial S. PI3 kinase/AKT pathway as a therapeutic target in multiple myeloma. Future Oncol 2007;3:639-47. [PMID: 18041916 DOI: 10.2217/14796694.3.6.639] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
311 Guertin DA, Sabatini DM. Cell Size Control. Encyclopedia of Life Sciences. Chichester: John Wiley & Sons, Ltd; 2001. [DOI: 10.1038/npg.els.0003359] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
312 Endersby R, Baker SJ. PTEN signaling in brain: neuropathology and tumorigenesis. Oncogene 2008;27:5416-30. [DOI: 10.1038/onc.2008.239] [Cited by in Crossref: 143] [Cited by in F6Publishing: 146] [Article Influence: 11.0] [Reference Citation Analysis]
313 Zahedi Abghari F, Moradi Y, Akouchekian M. PTEN gene mutations in patients with macrocephaly and classic autism: A systematic review. Med J Islam Repub Iran 2019;33:10. [PMID: 31086789 DOI: 10.34171/mjiri.33.10] [Reference Citation Analysis]
314 Yehia L, Eng C. 65 YEARS OF THE DOUBLE HELIX: One gene, many endocrine and metabolic syndromes: PTEN-opathies and precision medicine. Endocrine-Related Cancer 2018;25:T121-40. [DOI: 10.1530/erc-18-0162] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 9.3] [Reference Citation Analysis]
315 Yehia L, Ni Y, Eng C. Germline TTN variants are enriched in PTEN-wildtype Bannayan-Riley-Ruvalcaba syndrome. NPJ Genom Med 2017;2:37. [PMID: 29263846 DOI: 10.1038/s41525-017-0039-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
316 McCaffery P, Deutsch CK. Macrocephaly and the control of brain growth in autistic disorders. Prog Neurobiol 2005;77:38-56. [PMID: 16280193 DOI: 10.1016/j.pneurobio.2005.10.005] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.1] [Reference Citation Analysis]
317 Bibi Z, Ahmad J, Siddiqa A, Paracha RZ, Saeed T, Ali A, Janjua HA, Ullah S, Ben Abdallah E, Roux O. Formal Modeling of mTOR Associated Biological Regulatory Network Reveals Novel Therapeutic Strategy for the Treatment of Cancer. Front Physiol 2017;8:416. [PMID: 28659828 DOI: 10.3389/fphys.2017.00416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
318 Okumura K, Zhao M, Depinho RA, Furnari FB, Cavenee WK. Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor. Proc Natl Acad Sci U S A 2005;102:2703-6. [PMID: 15659546 DOI: 10.1073/pnas.0409370102] [Cited by in Crossref: 89] [Cited by in F6Publishing: 82] [Article Influence: 5.6] [Reference Citation Analysis]
319 Ai J, Pascal LE, O'Malley KJ, Dar JA, Isharwal S, Qiao Z, Ren B, Rigatti LH, Dhir R, Xiao W, Nelson JB, Wang Z. Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model. Oncogene 2014;33:2286-94. [PMID: 23708662 DOI: 10.1038/onc.2013.190] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
320 Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov. 2005;4:988-1004. [PMID: 16341064 DOI: 10.1038/nrd1902] [Cited by in Crossref: 1396] [Cited by in F6Publishing: 1303] [Article Influence: 93.1] [Reference Citation Analysis]
321 Wu IC, Orbach DB. Neurointerventional Management of High-Flow Vascular Malformations of the Head and Neck. Neuroimaging Clinics of North America 2009;19:219-40. [DOI: 10.1016/j.nic.2009.01.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
322 Xing L, Liu Q, Fu S, Li S, Yang L, Liu S, Hao J, Yu L, Duan H. PTEN Inhibits High Glucose-Induced Phenotypic Transition in Podocytes. J Cell Biochem 2015;116:1776-84. [PMID: 25736988 DOI: 10.1002/jcb.25136] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
323 Rimessi A, Pedriali G, Vezzani B, Tarocco A, Marchi S, Wieckowski MR, Giorgi C, Pinton P. Interorganellar calcium signaling in the regulation of cell metabolism: A cancer perspective. Semin Cell Dev Biol 2020;98:167-80. [PMID: 31108186 DOI: 10.1016/j.semcdb.2019.05.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
324 Kopelovich L, Shea-Herbert B. Heritable one-hit events defining cancer prevention? Cell Cycle 2013;12:2553-7. [PMID: 23907126 DOI: 10.4161/cc.25690] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
325 To KK, Tomlinson B. Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists. Br J Pharmacol 2013;170:1137-51. [PMID: 24032744 DOI: 10.1111/bph.12367] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
326 Lodish MB, Stratakis CA. Rare and unusual endocrine cancer syndromes with mutated genes. Semin Oncol 2010;37:680-90. [PMID: 21167385 DOI: 10.1053/j.seminoncol.2010.10.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
327 Li H, Zhu R, Wang L, Zhu T, Li Q, Chen Q, Wang H, Zhu H. PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast. Experimental and Molecular Pathology 2010;88:150-5. [DOI: 10.1016/j.yexmp.2009.09.016] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
328 Redondo P. Malformaciones vasculares (I). Concepto, clasificación, fisiopatogenia y manifestaciones clínicas. Actas Dermo-Sifiliográficas 2007;98:141-58. [DOI: 10.1016/s0001-7310(07)70038-8] [Cited by in Crossref: 51] [Article Influence: 3.6] [Reference Citation Analysis]
329 Tahmasebi S, Khoutorsky A, Mathews MB, Sonenberg N. Translation deregulation in human disease. Nat Rev Mol Cell Biol 2018;19:791-807. [PMID: 30038383 DOI: 10.1038/s41580-018-0034-x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 71] [Article Influence: 42.0] [Reference Citation Analysis]
330 Holly JMP, Biernacka K, Perks CM. Systemic Metabolism, Its Regulators, and Cancer: Past Mistakes and Future Potential. Front Endocrinol (Lausanne) 2019;10:65. [PMID: 30809194 DOI: 10.3389/fendo.2019.00065] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
331 Ha M, Chung JW, Hahm KB, Kim YJ, Lee W, An J, Kim DK, Kim MG. A case of Cowden syndrome diagnosed from multiple gastric polyposis. World J Gastroenterol 2012; 18(8): 861-864 [PMID: 22371648 DOI: 10.3748/wjg.v18.i8.861] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
332 Sawai H, Yasuda A, Ochi N, Ma J, Matsuo Y, Wakasugi T, Takahashi H, Funahashi H, Sato M, Takeyama H. Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival. BMC Gastroenterol. 2008;8:56. [PMID: 19036165 DOI: 10.1186/1471-230x-8-56] [Cited by in Crossref: 88] [Cited by in F6Publishing: 53] [Article Influence: 6.8] [Reference Citation Analysis]
333 Zhao L, Zhou N, Zhao P. Expression level of NEAT1 differentiates benign and malignant thyroid nodules by regulating NEAT1/miR‑9/PTEN and NEAT1/miR‑124/PDCD6 signalling. Int J Mol Med 2020;46:1661-70. [PMID: 32901835 DOI: 10.3892/ijmm.2020.4721] [Reference Citation Analysis]
334 Carracedo A, Pandolfi PP. The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene. 2008;27:5527-5541. [PMID: 18794886 DOI: 10.1038/onc.2008.247] [Cited by in Crossref: 565] [Cited by in F6Publishing: 541] [Article Influence: 43.5] [Reference Citation Analysis]
335 Krab LC, Goorden SM, Elgersma Y. Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases. Trends in Genetics 2008;24:498-510. [DOI: 10.1016/j.tig.2008.07.005] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
336 Negishi Y, Miya F, Hattori A, Johmura Y, Nakagawa M, Ando N, Hori I, Togawa T, Aoyama K, Ohashi K, Fukumura S, Mizuno S, Umemura A, Kishimoto Y, Okamoto N, Kato M, Tsunoda T, Yamasaki M, Kanemura Y, Kosaki K, Nakanishi M, Saitoh S. A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly. BMC Med Genet 2017;18:4. [PMID: 28086757 DOI: 10.1186/s12881-016-0363-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
337 Cecener G, Tunca B, Egeli U, Bekar A, Guler G, Vatan O, Tolunay S. Investigation of MMAC/PTEN gene mutations and protein expression in low grade gliomas. Cell Mol Neurobiol 2009;29:733-8. [PMID: 19350382 DOI: 10.1007/s10571-009-9397-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
338 Santoro M, Fusco A. New drugs in thyroid cancer. Arq Bras Endocrinol Metab 2007;51:857-61. [DOI: 10.1590/s0004-27302007000500025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
339 Happle R. The concept of type 2 segmental mosaicism, expanding from dermatology to general medicine. J Eur Acad Dermatol Venereol 2018;32:1075-88. [PMID: 29405433 DOI: 10.1111/jdv.14838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
340 Pritchard CC, Smith C, Marushchak T, Koehler K, Holmes H, Raskind W, Walsh T, Bennett RL. A mosaic PTEN mutation causing Cowden syndrome identified by deep sequencing. Genet Med 2013;15:1004-7. [PMID: 23619277 DOI: 10.1038/gim.2013.51] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
341 Darling TN. Hitting the mark in hamartoma syndromes. Adv Dermatol 2006;22:181-200. [PMID: 17249302 DOI: 10.1016/j.yadr.2006.09.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
342 Ngeow J, Eng C. PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol. Methods 2015;77-78:11-9. [PMID: 25461771 DOI: 10.1016/j.ymeth.2014.10.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
343 Kreis P, Leondaritis G, Lieberam I, Eickholt BJ. Subcellular targeting and dynamic regulation of PTEN: implications for neuronal cells and neurological disorders. Front Mol Neurosci 2014;7:23. [PMID: 24744697 DOI: 10.3389/fnmol.2014.00023] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 8.1] [Reference Citation Analysis]
344 Selvendiran K, Tong L, Vishwanath S, Bratasz A, Trigg NJ, Kutala VK, Hideg K, Kuppusamy P. EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression. J Biol Chem. 2007;282:28609-28618. [PMID: 17684018 DOI: 10.1074/jbc.M703796200] [Cited by in Crossref: 106] [Cited by in F6Publishing: 61] [Article Influence: 7.6] [Reference Citation Analysis]
345 Robinson S, Cohen AR. Cowden disease and Lhermitte-Duclos disease: an update. Case report and review of the literature. Neurosurg Focus 2006;20:E6. [PMID: 16459996 DOI: 10.3171/foc.2006.20.1.7] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
346 Zafeiriou DI, Ververi A, Dafoulis V, Kalyva E, Vargiami E. Autism spectrum disorders: the quest for genetic syndromes. Am J Med Genet B Neuropsychiatr Genet 2013;162B:327-66. [PMID: 23650212 DOI: 10.1002/ajmg.b.32152] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
347 Detanico T, St Clair JB, Aviszus K, Kirchenbaum G, Guo W, Wysocki LJ. Somatic mutagenesis in autoimmunity. Autoimmunity 2013;46:102-14. [PMID: 23249093 DOI: 10.3109/08916934.2012.757597] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
348 Djordjevic B, Broaddus RR. Selected Topics in the Molecular Pathology of Endometrial Carcinoma. Surg Pathol Clin 2011;4:131-47. [PMID: 26837291 DOI: 10.1016/j.path.2010.12.001] [Reference Citation Analysis]
349 Hertzler-Schaefer K, Mathew G, Somani AK, Tholpady S, Kadakia MP, Chen Y, Spandau DF, Zhang X. Pten loss induces autocrine FGF signaling to promote skin tumorigenesis. Cell Rep 2014;6:818-26. [PMID: 24582960 DOI: 10.1016/j.celrep.2014.01.045] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
350 Persico A. Autisms. Neural Circuit Development and Function in the Brain. Elsevier; 2013. pp. 651-94. [DOI: 10.1016/b978-0-12-397267-5.00045-5] [Cited by in Crossref: 8] [Article Influence: 1.0] [Reference Citation Analysis]
351 Gunji-Niitsu Y, Kumasaka T, Kitamura S, Hoshika Y, Hayashi T, Tokuda H, Morita R, Kobayashi E, Mitani K, Kikkawa M, Takahashi K, Seyama K. Benign clear cell "sugar" tumor of the lung in a patient with Birt-Hogg-Dubé syndrome: a case report. BMC Med Genet 2016;17:85. [PMID: 27871249 DOI: 10.1186/s12881-016-0350-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
352 Yilmaz OH, Morrison SJ. The PI-3kinase pathway in hematopoietic stem cells and leukemia-initiating cells: a mechanistic difference between normal and cancer stem cells. Blood Cells Mol Dis 2008;41:73-6. [PMID: 18387833 DOI: 10.1016/j.bcmd.2008.02.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
353 Mills JD, Chen BJ, Ueberham U, Arendt T, Janitz M. The Antisense Transcriptome and the Human Brain. J Mol Neurosci 2016;58:1-15. [PMID: 26697858 DOI: 10.1007/s12031-015-0694-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
354 Bellacosa A. Developmental disease and cancer: biological and clinical overlaps. Am J Med Genet A 2013;161A:2788-96. [PMID: 24123833 DOI: 10.1002/ajmg.a.36267] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
355 Boccone L, Dessì V, Serra G, Zibordi F, Loudianos G. Bannayan–Riley–Ruvalcaba syndrome with posterior subcapsular congenital cataract and a consensus sequence splicing PTEN mutation. Am J Med Genet 2008;146A:257-60. [DOI: 10.1002/ajmg.a.32086] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
356 Yotsumoto Y, Harada A, Tsugawa J, Ikura Y, Utsunomiya H, Miyatake S, Matsumoto N, Kanemura Y, Hashimoto-Tamaoki T. Infantile macrocephaly and multiple subcutaneous lipomas diagnosed with PTEN hamartoma tumor syndrome: A case report. Mol Clin Oncol 2020;12:329-35. [PMID: 32190315 DOI: 10.3892/mco.2020.1988] [Reference Citation Analysis]
357 Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, Janakiraman M, Schultz N, Hanrahan AJ, Pao W, Ladanyi M, Sander C, Heguy A, Holland EC, Paty PB, Mischel PS, Liau L, Cloughesy TF, Mellinghoff IK, Solit DB, Chan TA. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet 2010;42:77-82. [PMID: 19946270 DOI: 10.1038/ng.491] [Cited by in Crossref: 252] [Cited by in F6Publishing: 243] [Article Influence: 21.0] [Reference Citation Analysis]
358 Vanderver A, Tonduti D, Kahn I, Schmidt J, Medne L, Vento J, Chapman KA, Lanpher B, Pearl P, Gropman A, Lourenco C, Bamforth JS, Sharpe C, Pineda M, Schallner J, Bodamer O, Orcesi S, Oberstein SA, Sistermans EA, Yntema HG, Bonnemann C, Waldman AT, van der Knaap MS. Characteristic brain magnetic resonance imaging pattern in patients with macrocephaly and PTEN mutations. Am J Med Genet A 2014;164A:627-33. [PMID: 24375884 DOI: 10.1002/ajmg.a.36309] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 6.5] [Reference Citation Analysis]
359 van Bon BW, Balciuniene J, Fruhman G, Nagamani SC, Broome DL, Cameron E, Martinet D, Roulet E, Jacquemont S, Beckmann JS, Irons M, Potocki L, Lee B, Cheung SW, Patel A, Bellini M, Selicorni A, Ciccone R, Silengo M, Vetro A, Knoers NV, de Leeuw N, Pfundt R, Wolf B, Jira P, Aradhya S, Stankiewicz P, Brunner HG, Zuffardi O, Selleck SB, Lupski JR, de Vries BB. The phenotype of recurrent 10q22q23 deletions and duplications. Eur J Hum Genet 2011;19:400-8. [PMID: 21248748 DOI: 10.1038/ejhg.2010.211] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
360 Dijkstra KK, Blanchetot C, Boonstra J. Evasion of G1 Checkpoints in Cancer. In: Siddik ZH, editor. Checkpoint Controls and Targets in Cancer Therapy. Totowa: Humana Press; 2009. pp. 3-26. [DOI: 10.1007/978-1-60761-178-3_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
361 Walker RN, Murphy TJ, Wilkerson ML. Testicular Hamartomas in a Patient With Bannayan-Riley-Ruvalcaba Syndrome. Journal of Ultrasound in Medicine 2008;27:1245-8. [DOI: 10.7863/jum.2008.27.8.1245] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
362 Nadeau JH, Topol EJ. The genetics of health. Nat Genet 2006;38:1095-8. [PMID: 17006459 DOI: 10.1038/ng1006-1095] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
363 Chippagiri P, Banavar Ravi S, Patwa N. Multiple hamartoma syndrome with characteristic oral and cutaneous manifestations. Case Rep Dent 2013;2013:315109. [PMID: 24151559 DOI: 10.1155/2013/315109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
364 Reifenberger J. [Hereditary tumor syndromes. Cutaneous manifestations and molecular pathogenesis of Gorlin and Cowden syndromes]. Hautarzt 2004;55:942-51. [PMID: 15349693 DOI: 10.1007/s00105-004-0800-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
365 Baran JA, Tsai SD, Isaza A, Brodeur GM, MacFarland SP, Zelley K, Adams DM, Franco AT, Bauer AJ. The Clinical Spectrum of PTEN Hamartoma Tumor Syndrome: Exploring the Value of Thyroid Surveillance. Horm Res Paediatr 2020;93:634-42. [PMID: 33887726 DOI: 10.1159/000515731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
366 Womble PD, Hodges SL, Nolan SO, Binder MS, Holley AJ, Herrera R, Senger S, Kwok E, Narviaz DA, Faust A, Hernandez-Zegada CJ, Kwon RY, Lugo JN. A vitamin D enriched diet attenuates sex-specific behavioral deficits, increases the lifespan, but does not rescue bone abnormalities in a mouse model of cortical dysplasia. Epilepsy Behav 2021;124:108297. [PMID: 34509882 DOI: 10.1016/j.yebeh.2021.108297] [Reference Citation Analysis]
367 Rodríguez-Escudero I, Andrés-Pons A, Pulido R, Molina M, Cid VJ. Phosphatidylinositol 3-kinase-dependent activation of mammalian protein kinase B/Akt in Saccharomyces cerevisiae, an in vivo model for the functional study of Akt mutations. J Biol Chem 2009;284:13373-83. [PMID: 19307184 DOI: 10.1074/jbc.M807867200] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
368 Kazdoba TM, Leach PT, Crawley JN. Behavioral phenotypes of genetic mouse models of autism. Genes Brain Behav 2016;15:7-26. [PMID: 26403076 DOI: 10.1111/gbb.12256] [Cited by in Crossref: 82] [Cited by in F6Publishing: 75] [Article Influence: 13.7] [Reference Citation Analysis]
369 Gao S, Wang R, Dong S, Wu J, Perek B, Xia Z, Yao S, Wang T. Inactivation of TOPK Caused by Hyperglycemia Blocks Diabetic Heart Sensitivity to Sevoflurane Postconditioning by Impairing the PTEN/PI3K/Akt Signaling. Oxid Med Cell Longev 2021;2021:6657529. [PMID: 33986917 DOI: 10.1155/2021/6657529] [Reference Citation Analysis]
370 Hall JE, Abdollahian DJ, Sinard RJ, Eisele DW. Thyroid disease associated with cowden syndrome: A meta-analysis. Head Neck 2013;35:1189-94. [DOI: 10.1002/hed.22971] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
371 Chung JH, Ostrowski MC, Romigh T, Minaguchi T, Waite KA, Eng C. The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation. Hum Mol Genet. 2006;15:2553-2559. [PMID: 16849370 DOI: 10.1093/hmg/ddl177] [Cited by in Crossref: 77] [Cited by in F6Publishing: 75] [Article Influence: 5.1] [Reference Citation Analysis]
372 Feng F, Yehia L, Ni Y, Chang YS, Jhiang SM, Eng C. A Nonpump Function of Sodium Iodide Symporter in Thyroid Cancer via Cross-talk with PTEN Signaling. Cancer Res 2018;78:6121-33. [PMID: 30217930 DOI: 10.1158/0008-5472.CAN-18-1954] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
373 Braccini L, Ciraolo E, Martini M, Pirali T, Germena G, Rolfo K, Hirsch E. PI3K keeps the balance between metabolism and cancer. Advances in Biological Regulation 2012;52:389-405. [DOI: 10.1016/j.jbior.2012.04.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
374 Matsuda M, Takeshita K, Kurokawa T, Sakata S, Suzuki M, Yamashita E, Okamura Y, Nakagawa A. Crystal structure of the cytoplasmic phosphatase and tensin homolog (PTEN)-like region of Ciona intestinalis voltage-sensing phosphatase provides insight into substrate specificity and redox regulation of the phosphoinositide phosphatase activity. J Biol Chem 2011;286:23368-77. [PMID: 21543329 DOI: 10.1074/jbc.M110.214361] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
375 Restuccia DF, Hemmings BA. From man to mouse and back again: advances in defining tumor AKTivities in vivo. Dis Model Mech 2010;3:705-20. [PMID: 20940316 DOI: 10.1242/dmm.004671] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
376 Bakarakos P, Theohari I, Nomikos A, Mylona E, Papadimitriou C, Dimopoulos AM, Nakopoulou L. Immunohistochemical study of PTEN and phosphorylated mTOR proteins in familial and sporadic invasive breast carcinomas. Histopathology 2010;56:876-82. [PMID: 20636791 DOI: 10.1111/j.1365-2559.2010.03570.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
377 Chalhoub N, Kozma SC, Baker SJ. S6k1 is not required for Pten-deficient neuronal hypertrophy. Brain Res 2006;1100:32-41. [PMID: 16777079 DOI: 10.1016/j.brainres.2006.05.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
378 Conti S, Condò M, Posar A, Mari F, Resta N, Renieri A, Neri I, Patrizi A, Parmeggiani A. Phosphatase and tensin homolog (PTEN) gene mutations and autism: literature review and a case report of a patient with Cowden syndrome, autistic disorder, and epilepsy. J Child Neurol 2012;27:392-7. [PMID: 21960672 DOI: 10.1177/0883073811420296] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
379 Kyritsis AP, Bondy ML, Rao JS, Sioka C. Inherited predisposition to glioma. Neuro Oncol 2010;12:104-13. [PMID: 20150373 DOI: 10.1093/neuonc/nop011] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
380 Zhou XP, Marsh DJ, Morrison CD, Chaudhury AR, Maxwell M, Reifenberger G, Eng C. Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults. Am J Hum Genet. 2003;73:1191-1198. [PMID: 14566704 DOI: 10.1086/379382] [Cited by in Crossref: 125] [Cited by in F6Publishing: 94] [Article Influence: 6.9] [Reference Citation Analysis]
381 Solari F, Bourbon-piffaut A, Masse I, Payrastre B, Chan AM-, Billaud M. The human tumour suppressor PTEN regulates longevity and dauer formation in Caenorhabditis elegans. Oncogene 2005;24:20-7. [DOI: 10.1038/sj.onc.1207978] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
382 Fusco N, Sajjadi E, Venetis K, Gaudioso G, Lopez G, Corti C, Rocco EG, Criscitiello C, Malapelle U, Invernizzi M. PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine? Genes (Basel) 2020;11:E719. [PMID: 32605290 DOI: 10.3390/genes11070719] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
383 Blando JM, Carbajal S, Abel E, Beltran L, Conti C, Fischer S, DiGiovanni J. Cooperation between Stat3 and Akt signaling leads to prostate tumor development in transgenic mice. Neoplasia 2011;13:254-65. [PMID: 21390188 DOI: 10.1593/neo.101388] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
384 Lopiccolo J, Ballas MS, Dennis PA. PTEN hamartomatous tumor syndromes (PHTS): rare syndromes with great relevance to common cancers and targeted drug development. Crit Rev Oncol Hematol 2007;63:203-14. [PMID: 17643312 DOI: 10.1016/j.critrevonc.2007.06.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
385 Cao Z, Song JH, Kim CJ, Cho YG, Kim SY, Nam SW, Lee JY, Park WS. Absence of E17K mutation in the pleckstrin homology domain of AKT1 in gastrointestinal and liver cancers in the Korean population. APMIS 2008;116:530-3. [PMID: 18754328 DOI: 10.1111/j.1600-0463.2008.00998.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
386 Hemminki K, Eng C, Chen B. Familial Risks for Nonmedullary Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism 2005;90:5747-53. [DOI: 10.1210/jc.2005-0935] [Cited by in Crossref: 114] [Cited by in F6Publishing: 86] [Article Influence: 7.1] [Reference Citation Analysis]
387 Ni Y, He X, Chen J, Moline J, Mester J, Orloff MS, Ringel MD, Eng C. Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53. Hum Mol Genet 2012;21:300-10. [PMID: 21979946 DOI: 10.1093/hmg/ddr459] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 6.6] [Reference Citation Analysis]
388 Burke WM, Orr J, Leitao M, Salom E, Gehrig P, Olawaiye AB, Brewer M, Boruta D, Villella J, Herzog T, Abu Shahin F. Endometrial cancer: A review and current management strategies: Part I. Gynecologic Oncology 2014;134:385-92. [DOI: 10.1016/j.ygyno.2014.05.018] [Cited by in Crossref: 220] [Cited by in F6Publishing: 189] [Article Influence: 31.4] [Reference Citation Analysis]
389 Johnston SB, Raines RT. Catalysis by the tumor-suppressor enzymes PTEN and PTEN-L. PLoS One 2015;10:e0116898. [PMID: 25607987 DOI: 10.1371/journal.pone.0116898] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
390 Lodish MB, Stratakis CA. Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes. Best Pract Res Clin Endocrinol Metab 2010;24:439-49. [PMID: 20833335 DOI: 10.1016/j.beem.2010.02.002] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 5.2] [Reference Citation Analysis]
391 Bhargava R, Au Yong KJ, Leonard N. Bannayan-Riley-Ruvalcaba syndrome: MRI neuroimaging features in a series of 7 patients. AJNR Am J Neuroradiol 2014;35:402-6. [PMID: 23907246 DOI: 10.3174/ajnr.A3680] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
392 Song MS, Carracedo A, Salmena L, Song SJ, Egia A, Malumbres M, Pandolfi PP. Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell. 2011;144:187-199. [PMID: 21241890 DOI: 10.1016/j.cell.2010.12.020] [Cited by in Crossref: 259] [Cited by in F6Publishing: 263] [Article Influence: 25.9] [Reference Citation Analysis]
393 Borić Škaro D, Filipović N, Mizdrak M, Glavina Durdov M, Šolić I, Kosović I, Lozić M, Racetin A, Jurić M, Ljutić D, Vukojević K. SATB1 and PTEN expression patterns in biopsy proven kidney diseases. Acta Histochem 2020;122:151631. [PMID: 33152540 DOI: 10.1016/j.acthis.2020.151631] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
394 Kim DK, Myung SJ, Yang SK, Hong SS, Kim KJ, Byeon JS, Lee GH, Kim JH, Min YI, Lee SM. Analysis of PTEN gene mutations in Korean patients with Cowden syndrome and polyposis syndrome. Dis Colon Rectum. 2005;48:1714-1722. [PMID: 16007494 DOI: 10.1007/s10350-005-0130-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
395 Jurado S, Benoist M, Lario A, Knafo S, Petrok CN, Esteban JA. PTEN is recruited to the postsynaptic terminal for NMDA receptor-dependent long-term depression. EMBO J 2010;29:2827-40. [PMID: 20628354 DOI: 10.1038/emboj.2010.160] [Cited by in Crossref: 96] [Cited by in F6Publishing: 95] [Article Influence: 8.7] [Reference Citation Analysis]
396 Evangelisti C, Martelli A. The PI3K/Akt/mTOR Pathway. Encyclopedia of Cell Biology. Elsevier; 2016. pp. 128-35. [DOI: 10.1016/b978-0-12-394447-4.30015-3] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
397 Zhai Y, Zhang Y, Nan K, Liang X. Reduced expression levels of PTEN are associated with decreased sensitivity of HCC827 cells to icotinib. Oncol Lett 2017;13:3233-8. [PMID: 28521430 DOI: 10.3892/ol.2017.5829] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
398 Blumenthal GM, Dennis PA. PTEN hamartoma tumor syndromes. Eur J Hum Genet. 2008;16:1289-1300. [PMID: 18781191 DOI: 10.1038/ejhg.2008.162] [Cited by in Crossref: 169] [Cited by in F6Publishing: 125] [Article Influence: 13.0] [Reference Citation Analysis]
399 Argente J, Sotos JF. [Overgrowth with and without obesity: clinical and molecular principles]. An Pediatr (Barc) 2012;76:161.e1-28. [PMID: 22098786 DOI: 10.1016/j.anpedi.2011.09.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
400 Ekmektzoglou K, Demestiha T, Troupis G, Xanthos T. Commonest Overgrowth Syndromes. Fetal and Pediatric Pathology 2012;31:94-111. [DOI: 10.3109/15513815.2011.650293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
401 Barreras P, Gailloud P, Pardo CA. A longitudinally extensive myelopathy associated with multiple spinal arteriovenous fistulas in a patient with Cowden syndrome: a case report. The Spine Journal 2018;18:e1-5. [DOI: 10.1016/j.spinee.2016.01.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
402 Ubriani R, Grossman ME. Facial papules as a marker of internal malignancy. Med Clin North Am 2009;93:1305-31. [PMID: 19932333 DOI: 10.1016/j.mcna.2009.08.002] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
403 Li G, Zhang Z, Zhang J, Jin T, Liang H, Gong L, Cui G, Yang H, He S, Zhang Y, Gao G. Occipital anaplastic oligodendroglioma with multiple organ metastases after a short clinical course: a case report and literature review. Diagn Pathol 2014;9:17. [PMID: 24447608 DOI: 10.1186/1746-1596-9-17] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
404 Scoazec J. Les polypes gastriques: pathologie et génétique. Annales de Pathologie 2006;26:173-99. [DOI: 10.1016/s0242-6498(06)70702-7] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
405 Isik E, Simsir OS, Solmaz AE, Onay H, Atik T, Aykut A, Durmaz A, Cogulu O, Ozkinay F. Clinical and molecular aspects of PTEN mutations in 10 pediatric patients. Annals of Human Genetics 2020;84:324-30. [DOI: 10.1111/ahg.12380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
406 Committee opinion no.634: Hereditary cancer syndromes and risk assessment. Obstet Gynecol. 2015;125:1538-1543. [PMID: 26000542 DOI: 10.1097/01.aog.0000466373.71146.51] [Cited by in Crossref: 29] [Cited by in F6Publishing: 6] [Article Influence: 4.8] [Reference Citation Analysis]
407 Ai Y, Zhou Q, Li L, Pan Z, Guo M, Han J. Interference of P-REX2a may inhibit proliferation and reverse the resistance of SGC7901 cells to doxorubicin. Oncol Lett 2018;15:3185-91. [PMID: 29435055 DOI: 10.3892/ol.2017.7693] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
408 Prat J, Gallardo A, Cuatrecasas M, Catasús L. Endometrial carcinoma: pathology and genetics. Pathology 2007;39:72-87. [DOI: 10.1080/00313020601136153] [Cited by in Crossref: 124] [Cited by in F6Publishing: 107] [Article Influence: 8.9] [Reference Citation Analysis]
409 Schmid GL, Kässner F, Uhlig HH, Körner A, Kratzsch J, Händel N, Zepp FP, Kowalzik F, Laner A, Starke S, Wilhelm FK, Schuster S, Viehweger A, Hirsch W, Kiess W, Garten A. Sirolimus treatment of severe PTEN hamartoma tumor syndrome: case report and in vitro studies. Pediatr Res 2014;75:527-34. [PMID: 24366516 DOI: 10.1038/pr.2013.246] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
410 Delnatte C, Sanlaville D, Mougenot JF, Vermeesch JR, Houdayer C, Blois MC, Genevieve D, Goulet O, Fryns JP, Jaubert F. Contiguous gene deletion within chromosome arm 10q is associated with juvenile polyposis of infancy, reflecting cooperation between the BMPR1A and PTEN tumor-suppressor genes. Am J Hum Genet. 2006;78:1066-1074. [PMID: 16685657 DOI: 10.1086/504301] [Cited by in Crossref: 89] [Cited by in F6Publishing: 73] [Article Influence: 5.9] [Reference Citation Analysis]
411 Govender D, Chetty R. Gene of the month: PTEN. J Clin Pathol 2012;65:601-3. [PMID: 22416141 DOI: 10.1136/jclinpath-2012-200711] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
412 Plun-Favreau H, Lewis PA, Hardy J, Martins LM, Wood NW. Cancer and neurodegeneration: between the devil and the deep blue sea. PLoS Genet 2010;6:e1001257. [PMID: 21203498 DOI: 10.1371/journal.pgen.1001257] [Cited by in Crossref: 95] [Cited by in F6Publishing: 96] [Article Influence: 8.6] [Reference Citation Analysis]
413 Venturini G, Moulin AP, Deprez M, Uffer S, Bottani A, Zografos L, Rivolta C. Clinicopathologic and molecular analysis of a choroidal pigmented schwannoma in the context of a PTEN hamartoma tumor syndrome. Ophthalmology 2012;119:857-64. [PMID: 22281088 DOI: 10.1016/j.ophtha.2011.09.057] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
414 Wang Y, He X, Ngeow J, Eng C. GATA2 negatively regulates PTEN by preventing nuclear translocation of androgen receptor and by androgen-independent suppression of PTEN transcription in breast cancer. Hum Mol Genet 2012;21:569-76. [PMID: 22021428 DOI: 10.1093/hmg/ddr491] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
415 Lacey JV Jr, Yang H, Gaudet MM, Dunning A, Lissowska J, Sherman ME, Peplonska B, Brinton LA, Healey CS, Ahmed S, Pharoah P, Easton D, Chanock S, Garcia-Closas M. Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study. Gynecol Oncol 2011;120:167-73. [PMID: 21093899 DOI: 10.1016/j.ygyno.2010.10.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
416 Shen WH, Balajee AS, Wang J, Wu H, Eng C, Pandolfi PP, Yin Y. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 2007;128:157-70. [PMID: 17218262 DOI: 10.1016/j.cell.2006.11.042] [Cited by in Crossref: 659] [Cited by in F6Publishing: 621] [Article Influence: 47.1] [Reference Citation Analysis]
417 Gozzelino L, De Santis MC, Gulluni F, Hirsch E, Martini M. PI(3,4)P2 Signaling in Cancer and Metabolism. Front Oncol 2020;10:360. [PMID: 32296634 DOI: 10.3389/fonc.2020.00360] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
418 Pascal LE, Ai J, Masoodi KZ, Wang Y, Wang D, Eisermann K, Rigatti LH, O'Malley KJ, Ma HM, Wang X, Dar JA, Parwani AV, Simons BW, Ittman MM, Li L, Davies BJ, Wang Z. Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice. PLoS One 2013;8:e79542. [PMID: 24260246 DOI: 10.1371/journal.pone.0079542] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
419 Han S, Ritzenthaler JD, Zheng Y, Roman J. PPARbeta/delta agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-kappaB signals. Am J Physiol Lung Cell Mol Physiol 2008;294:L1238-49. [PMID: 18390835 DOI: 10.1152/ajplung.00017.2008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
420 Wang QK. Update on the molecular genetics of vascular anomalies. Lymphat Res Biol 2005;3:226-33. [PMID: 16379592 DOI: 10.1089/lrb.2005.3.226] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
421 Gil A, Andrés-Pons A, Fernández E, Valiente M, Torres J, Cervera J, Pulido R. Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs. Mol Biol Cell 2006;17:4002-13. [PMID: 16807353 DOI: 10.1091/mbc.e06-05-0380] [Cited by in Crossref: 100] [Cited by in F6Publishing: 72] [Article Influence: 6.7] [Reference Citation Analysis]
422 He J, de la Monte S, Wands JR. The p85beta regulatory subunit of PI3K serves as a substrate for PTEN protein phosphatase activity during insulin mediated signaling. Biochem Biophys Res Commun 2010;397:513-9. [PMID: 20515662 DOI: 10.1016/j.bbrc.2010.05.146] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
423 Wang X, Jiang X. PTEN: a default gate-keeping tumor suppressor with a versatile tail. Cell Res. 2008;18:807-816. [PMID: 18626510 DOI: 10.1038/cr.2008.83] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
424 Sasaki T, Sasaki J, Watanabe K, Suzuki A. Non-invasive visualization of the lipid product of class I PI3K in transgenic mouse models. Biochemical Society Transactions 2007;35:215-8. [DOI: 10.1042/bst0350215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
425 Fine B, Hodakoski C, Koujak S, Su T, Saal LH, Maurer M, Hopkins B, Keniry M, Sulis ML, Mense S, Hibshoosh H, Parsons R. Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a. Science 2009;325:1261-5. [PMID: 19729658 DOI: 10.1126/science.1173569] [Cited by in Crossref: 168] [Cited by in F6Publishing: 152] [Article Influence: 14.0] [Reference Citation Analysis]
426 Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 2007;7:847-859. [PMID: 17943136 DOI: 10.1038/nrc2223] [Cited by in Crossref: 688] [Cited by in F6Publishing: 686] [Article Influence: 49.1] [Reference Citation Analysis]
427 Zak M, Ledbetter M, Maertens P. Infantile Lhermitte-Duclos Disease Treated Successfully With Rapamycin. J Child Neurol 2017;32:322-6. [DOI: 10.1177/0883073816681340] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
428 McDermott SP, Wicha MS. Targeting breast cancer stem cells. Mol Oncol. 2010;4:404-419. [PMID: 20599450 DOI: 10.1016/j.molonc. 2010.06.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
429 Chow LM, Baker SJ. PTEN function in normal and neoplastic growth. Cancer Letters 2006;241:184-96. [DOI: 10.1016/j.canlet.2005.11.042] [Cited by in Crossref: 180] [Cited by in F6Publishing: 174] [Article Influence: 12.0] [Reference Citation Analysis]
430 Farooq A, Walker LJ, Bowling J, Audisio RA. Cowden syndrome. Cancer Treat Rev. 2010;36:577-583. [PMID: 20580873 DOI: 10.1016/j.ctrv.2010.04.002] [Cited by in Crossref: 81] [Cited by in F6Publishing: 61] [Article Influence: 7.4] [Reference Citation Analysis]
431 Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005;5:341-354. [PMID: 15864276 DOI: 10.1038/nrc1609] [Cited by in Crossref: 2230] [Cited by in F6Publishing: 2039] [Article Influence: 139.4] [Reference Citation Analysis]
432 Bononi A, Agnoletto C, De Marchi E, Marchi S, Patergnani S, Bonora M, Giorgi C, Missiroli S, Poletti F, Rimessi A. Protein kinases and phosphatases in the control of cell fate. Enzyme Res. 2011;2011:329098. [PMID: 21904669 DOI: 10.4061/2011/329098] [Cited by in Crossref: 147] [Cited by in F6Publishing: 145] [Article Influence: 14.7] [Reference Citation Analysis]
433 Santoro M, Carlomagno F. Drug insight: Small-molecule inhibitors of protein kinases in the treatment of thyroid cancer. Nat Clin Pract Endocrinol Metab 2006;2:42-52. [PMID: 16932252 DOI: 10.1038/ncpendmet0073] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
434 Frazier TW. Autism Spectrum Disorder Associated with Germline Heterozygous PTEN Mutations. Cold Spring Harb Perspect Med 2019;9:a037002. [PMID: 31307976 DOI: 10.1101/cshperspect.a037002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
435 Song MS, Pandolfi PP. The HECT family of E3 ubiquitin ligases and PTEN. Semin Cancer Biol 2021:S1044-579X(21)00182-6. [PMID: 34129913 DOI: 10.1016/j.semcancer.2021.06.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
436 Valiente M, Andres-Pons A, Gomar B, Torres J, Gil A, Tapparel C, Antonarakis SE, Pulido R. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. J Biol Chem. 2005;280:28936-28943. [PMID: 15951562 DOI: 10.1074/jbc.M504761200] [Cited by in Crossref: 150] [Cited by in F6Publishing: 80] [Article Influence: 9.4] [Reference Citation Analysis]
437 Chuffa LGDA, Lupi-júnior LA, Costa AB, Amorim JPDA, Seiva FRF. The role of sex hormones and steroid receptors on female reproductive cancers. Steroids 2017;118:93-108. [DOI: 10.1016/j.steroids.2016.12.011] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 16.3] [Reference Citation Analysis]
438 Yune TY, Byun JY. Expression of PTEN and phosphorylated Akt in human cholesteatoma epithelium. Acta Otolaryngol 2009;129:501-6. [PMID: 18615333 DOI: 10.1080/00016480802258802] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
439 Guertin DA, Sabatini DM. An expanding role for mTOR in cancer. Trends Mol Med. 2005;11:353-361. [PMID: 16002336 DOI: 10.1016/j.molmed.2005.06.007] [Cited by in Crossref: 365] [Cited by in F6Publishing: 330] [Article Influence: 22.8] [Reference Citation Analysis]
440 Joseph Jerry D, Griner NB, Tao L. TUMOR SUPPRESSOR PATHWAYS AND CELLULAR ORIGINS OF BREAST CANCER: NEW COMPLEXITIES AND NEW HOPES. Nano LIFE 2012;01:1-16. [DOI: 10.1142/s179398441000002x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
441 Marchi S, Giorgi C, Oparka M, Duszynski J, Wieckowski MR, Pinton P. Oncogenic and oncosuppressive signal transduction at mitochondria-associated endoplasmic reticulum membranes. Mol Cell Oncol 2014;1:e956469. [PMID: 27308328 DOI: 10.4161/23723548.2014.956469] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
442 Wu D. Signaling mechanisms for regulation of chemotaxis. Cell Res 2005;15:52-6. [PMID: 15686628 DOI: 10.1038/sj.cr.7290265] [Cited by in Crossref: 60] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
443 Pulido R, van Huijsduijnen RH. Protein tyrosine phosphatases: dual-specificity phosphatases in health and disease: DSPs in health and disease. FEBS Journal 2008;275:848-66. [DOI: 10.1111/j.1742-4658.2008.06250.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 5.5] [Reference Citation Analysis]
444 Timur AA, Driscoll DJ, Wang Q. Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis. Cell Mol Life Sci 2005;62:1434-47. [PMID: 15905966 DOI: 10.1007/s00018-005-4523-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
445 Marcotte E, Boone C, Babu MM, Gavin AC. Network Biology editorial 2013. Mol Biosyst 2013;9:1557-8. [PMID: 23712464 DOI: 10.1039/c3mb90018e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
446 Gurunathan A, Ricci K, Iacobas I, Rednam SP, Wusik K, Fei L, Hammilll AM. Impact of vascular anomalies on the PTEN phenotype in children and young adults. Pediatr Blood Cancer 2020;67:e28258. [PMID: 32196895 DOI: 10.1002/pbc.28258] [Reference Citation Analysis]
447 Yamazaki K, Eng C, Kuznetsov SA, Reinisch J, Yamashita DD, Walker J, Cheung C, Robey PG, Yen SL. Missense mutation in the PTEN promoter of a patient with hemifacial hyperplasia. Bonekey Rep 2015;4:654. [PMID: 26229595 DOI: 10.1038/bonekey.2015.21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
448 Lasarge CL, Danzer SC. Mechanisms regulating neuronal excitability and seizure development following mTOR pathway hyperactivation. Front Mol Neurosci 2014;7:18. [PMID: 24672426 DOI: 10.3389/fnmol.2014.00018] [Cited by in Crossref: 88] [Cited by in F6Publishing: 86] [Article Influence: 12.6] [Reference Citation Analysis]
449 Milella M, Falcone I, Conciatori F, Cesta Incani U, Del Curatolo A, Inzerilli N, Nuzzo CM, Vaccaro V, Vari S, Cognetti F, Ciuffreda L. PTEN: Multiple Functions in Human Malignant Tumors. Front Oncol 2015;5:24. [PMID: 25763354 DOI: 10.3389/fonc.2015.00024] [Cited by in Crossref: 222] [Cited by in F6Publishing: 233] [Article Influence: 37.0] [Reference Citation Analysis]
450 Djaafri I, Khayati F, Menashi S, Tost J, Podgorniak MP, Sadoux A, Daunay A, Teixeira L, Soulier J, Idbaih A, Setterblad N, Fauvel F, Calvo F, Janin A, Lebbé C, Mourah S. A novel tumor suppressor function of Kindlin-3 in solid cancer. Oncotarget 2014;5:8970-85. [PMID: 25344860 DOI: 10.18632/oncotarget.2125] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
451 Kethman W, Rao A, Devereaux K, Ouellet E, Kin C. Say What? Bannayan-Riley-Ruvalcaba Syndrome Presenting with Gastrointestinal Bleeding Due to Hamartoma-Induced Intussusception. Dig Dis Sci 2017;62:2293-7. [PMID: 28168574 DOI: 10.1007/s10620-016-4443-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
452 Hynes NE. Targeting ERBB receptors in cancer. Recent Results Cancer Res 2007;172:45-57. [PMID: 17607935 DOI: 10.1007/978-3-540-31209-3_4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
453 Kanitakis J. Adnexal tumours of the skin as markers of cancer-prone syndromes. Journal of the European Academy of Dermatology and Venereology 2010;24:379-87. [DOI: 10.1111/j.1468-3083.2009.03420.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
454 Schepis C, Greco D, Siragusa M, Romano C. Cerebriform plantar hyperplasia: the major cutaneous feature of Proteus syndrome. Int J Dermatol 2008;47:374-6. [DOI: 10.1111/j.1365-4632.2008.03440.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
455 Slavin TP, Wiesner GL. Developmental defects and childhood cancer. Curr Opin Pediatr 2009;21:717-23. [PMID: 19812499 DOI: 10.1097/MOP.0b013e328332c612] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
456 Hafizi S, Ibraimi F, Dahlbäck B. C1‐TEN is a negative regulator of the Akt/PKB signal transduction pathway and inhibits cell survival, proliferation, and migration. FASEB j 2005;19:971-3. [DOI: 10.1096/fj.04-2532fje] [Cited by in Crossref: 76] [Cited by in F6Publishing: 61] [Article Influence: 4.8] [Reference Citation Analysis]
457 Hulbert SW, Jiang YH. Monogenic mouse models of autism spectrum disorders: Common mechanisms and missing links. Neuroscience 2016;321:3-23. [PMID: 26733386 DOI: 10.1016/j.neuroscience.2015.12.040] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
458 Page DT, Kuti OJ, Prestia C, Sur M. Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior. Proc Natl Acad Sci U S A 2009;106:1989-94. [PMID: 19208814 DOI: 10.1073/pnas.0804428106] [Cited by in Crossref: 106] [Cited by in F6Publishing: 103] [Article Influence: 8.8] [Reference Citation Analysis]
459 Blando J, Moore T, Hursting S, Jiang G, Saha A, Beltran L, Shen J, Repass J, Strom S, DiGiovanni J. Dietary energy balance modulates prostate cancer progression in Hi-Myc mice. Cancer Prev Res (Phila) 2011;4:2002-14. [PMID: 21952584 DOI: 10.1158/1940-6207.CAPR-11-0182] [Cited by in Crossref: 56] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
460 Stevens HE, Smith KM, Rash BG, Vaccarino FM. Neural stem cell regulation, fibroblast growth factors, and the developmental origins of neuropsychiatric disorders. Front Neurosci 2010;4:59. [PMID: 20877431 DOI: 10.3389/fnins.2010.00059] [Cited by in Crossref: 11] [Cited by in F6Publishing: 33] [Article Influence: 1.0] [Reference Citation Analysis]
461 Brugarolas J, Kaelin WG. Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes. Cancer Cell. 2004;6:7-10. [PMID: 15261137 DOI: 10.1016/j.ccr.2004.06.020] [Cited by in Crossref: 126] [Cited by in F6Publishing: 110] [Article Influence: 7.4] [Reference Citation Analysis]
462 Piccione M, Fragapane T, Antona V, Giachino D, Cupido F, Corsello G. PTEN hamartoma tumor syndromes in childhood: Description of two cases and a proposal for follow-up protocol. Am J Med Genet 2013;161:2902-8. [DOI: 10.1002/ajmg.a.36266] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
463 Ni Y, Seballos S, Fletcher B, Romigh T, Yehia L, Mester J, Senter L, Niazi F, Saji M, Ringel MD, LaFramboise T, Eng C. Germline compound heterozygous poly-glutamine deletion in USF3 may be involved in predisposition to heritable and sporadic epithelial thyroid carcinoma. Hum Mol Genet 2017;26:243-57. [PMID: 28011713 DOI: 10.1093/hmg/ddw382] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
464 Alfieri R, Giovannetti E, Bonelli M, Cavazzoni A. New Treatment Opportunities in Phosphatase and Tensin Homolog (PTEN)-Deficient Tumors: Focus on PTEN/Focal Adhesion Kinase Pathway. Front Oncol 2017;7:170. [PMID: 28848709 DOI: 10.3389/fonc.2017.00170] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
465 Stokoe D, Costello JF. Phosphatase and tensin homologue growth suppression without phosphatase. Proc Natl Acad Sci U S A 2005;102:2677-8. [PMID: 15710873 DOI: 10.1073/pnas.0500089102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
466 Song MS, Salmena L, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol. 2012;13:283-296. [PMID: 22473468 DOI: 10.1038/nrm3330] [Cited by in Crossref: 1129] [Cited by in F6Publishing: 1184] [Article Influence: 125.4] [Reference Citation Analysis]
467 Ligon AH, Moore SD, Parisi MA, Mealiffe ME, Harris DJ, Ferguson HL, Quade BJ, Morton CC. Constitutional rearrangement of the architectural factor HMGA2: a novel human phenotype including overgrowth and lipomas. Am J Hum Genet 2005;76:340-8. [PMID: 15593017 DOI: 10.1086/427565] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 5.3] [Reference Citation Analysis]
468 Tigli H, Seven D, Tunc M, Sanli O, Basaran S, Ulutin T, Buyru N. LKB1 mutations and their correlation with LKB1 and Rheb expression in bladder cancer. Mol Carcinog 2013;52:660-5. [DOI: 10.1002/mc.21902] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
469 Marone R, Cmiljanovic V, Giese B, Wymann MP. Targeting phosphoinositide 3-kinase: moving towards therapy. Biochim Biophys Acta 2008;1784:159-85. [PMID: 17997386 DOI: 10.1016/j.bbapap.2007.10.003] [Cited by in Crossref: 405] [Cited by in F6Publishing: 408] [Article Influence: 28.9] [Reference Citation Analysis]
470 Nguyen HL, Boon LM, Vikkula M. Genetics of vascular anomalies. Semin Pediatr Surg 2020;29:150967. [PMID: 33069286 DOI: 10.1016/j.sempedsurg.2020.150967] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
471 Tan YY, McGaughran J, Ferguson K, Walsh MD, Buchanan DD, Young JP, Webb PM, Obermair A, Spurdle AB; ANECS Group. Improving identification of lynch syndrome patients: a comparison of research data with clinical records. Int J Cancer 2013;132:2876-83. [PMID: 23225370 DOI: 10.1002/ijc.27978] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
472 Smith IN, Thacker S, Seyfi M, Cheng F, Eng C. Conformational Dynamics and Allosteric Regulation Landscapes of Germline PTEN Mutations Associated with Autism Compared to Those Associated with Cancer. Am J Hum Genet 2019;104:861-78. [PMID: 31006514 DOI: 10.1016/j.ajhg.2019.03.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
473 Wang H, Karikomi M, Naidu S, Rajmohan R, Caserta E, Chen HZ, Rawahneh M, Moffitt J, Stephens JA, Fernandez SA, Weinstein M, Wang D, Sadee W, La Perle K, Stromberg P, Rosol TJ, Eng C, Ostrowski MC, Leone G. Allele-specific tumor spectrum in pten knockin mice. Proc Natl Acad Sci U S A 2010;107:5142-7. [PMID: 20194734 DOI: 10.1073/pnas.0912524107] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
474 Bononi A, Bonora M, Marchi S, Missiroli S, Poletti F, Giorgi C, Pandolfi PP, Pinton P. Identification of PTEN at the ER and MAMs and its regulation of Ca(2+) signaling and apoptosis in a protein phosphatase-dependent manner. Cell Death Differ 2013;20:1631-43. [PMID: 23811847 DOI: 10.1038/cdd.2013.77] [Cited by in Crossref: 167] [Cited by in F6Publishing: 159] [Article Influence: 20.9] [Reference Citation Analysis]
475 Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet. 2005;37:19-24. [PMID: 15624019 DOI: 10.1038/ng1494] [Cited by in Crossref: 682] [Cited by in F6Publishing: 662] [Article Influence: 42.6] [Reference Citation Analysis]
476 Backman SA, Ghazarian D, So K, Sanchez O, Wagner KU, Hennighausen L, Suzuki A, Tsao MS, Chapman WB, Stambolic V, Mak TW. Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. Proc Natl Acad Sci U S A 2004;101:1725-30. [PMID: 14747659 DOI: 10.1073/pnas.0308217100] [Cited by in Crossref: 119] [Cited by in F6Publishing: 111] [Article Influence: 7.0] [Reference Citation Analysis]
477 Romano C, Schepis C. PTEN gene: a model for genetic diseases in dermatology. ScientificWorldJournal 2012;2012:252457. [PMID: 22623890 DOI: 10.1100/2012/252457] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
478 Ranji P, Salmani Kesejini T, Saeedikhoo S, Alizadeh AM. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance. Tumor Biol 2016;37:13059-75. [DOI: 10.1007/s13277-016-5294-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
479 Markman B, Atzori F, Pérez-García J, Tabernero J, Baselga J. Status of PI3K inhibition and biomarker development in cancer therapeutics. Ann Oncol. 2010;21:683-691. [PMID: 19713247 DOI: 10.1093/annonc/mdp347] [Cited by in Crossref: 109] [Cited by in F6Publishing: 96] [Article Influence: 9.1] [Reference Citation Analysis]
480 Wang W, El-Deiry WS. Targeting FOXO kills two birds with one stone. Chem Biol 2004;11:16-8. [PMID: 15112990 DOI: 10.1016/j.chembiol.2004.01.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
481 Ni Y, Zbuk KM, Sadler T, Patocs A, Lobo G, Edelman E, Platzer P, Orloff MS, Waite KA, Eng C. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Am J Hum Genet 2008;83:261-8. [PMID: 18678321 DOI: 10.1016/j.ajhg.2008.07.011] [Cited by in Crossref: 156] [Cited by in F6Publishing: 126] [Article Influence: 12.0] [Reference Citation Analysis]
482 Al-Thihli K, Palma L, Marcus V, Cesari M, Kushner YB, Barkun A, Foulkes WD. A case of Cowden's syndrome presenting with gastric carcinomas and gastrointestinal polyposis. Nat Clin Pract Gastroenterol Hepatol 2009;6:184-9. [PMID: 19190598 DOI: 10.1038/ncpgasthep1359] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
483 Kreger J, Howell J, Zlotoff B. Cutaneous clues: a genetic disorder diagnosed by dermatologic findings. J Pediatr 2014;164:422. [PMID: 24210926 DOI: 10.1016/j.jpeds.2013.08.067] [Reference Citation Analysis]
484 Cortés-Sempere M, de Miguel MP, Pernía O, Rodriguez C, de Castro Carpeño J, Nistal M, Conde E, López-Ríos F, Belda-Iniesta C, Perona R, Ibanez de Caceres I. IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer. Oncogene 2013;32:1274-83. [PMID: 22543588 DOI: 10.1038/onc.2012.146] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
485 Balci TB, Davila J, Lewis D, Boafo A, Sell E, Richer J, Nikkel SM, Armour CM, Tomiak E, Lines MA, Sawyer SL. Broad spectrum of neuropsychiatric phenotypes associated with white matter disease in PTEN hamartoma tumor syndrome. Am J Med Genet B Neuropsychiatr Genet 2018;177:101-9. [PMID: 29152901 DOI: 10.1002/ajmg.b.32610] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
486 He X, Saji M, Radhakrishnan D, Romigh T, Ngeow J, Yu Q, Wang Y, Ringel MD, Eng C. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome. J Clin Endocrinol Metab 2012;97:E2179-87. [PMID: 22962422 DOI: 10.1210/jc.2012-1991] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
487 McGarrity TJ, Amos C. Less common colorectal cancer predisposition syndromes. Surg Oncol Clin N Am 2009;18:647-61. [PMID: 19793572 DOI: 10.1016/j.soc.2009.07.005] [Reference Citation Analysis]
488 Witman PM. More than just a bump: the hamartoma syndromes. Adv Dermatol 2006;22:157-80. [PMID: 17249301 DOI: 10.1016/j.yadr.2006.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
489 Mirzaa G, Ashwal S, Dobyns WB. Disorders of Brain Size. Swaiman's Pediatric Neurology. Elsevier; 2012. pp. 173-201. [DOI: 10.1016/b978-1-4377-0435-8.00025-1] [Cited by in Crossref: 6] [Article Influence: 0.7] [Reference Citation Analysis]
490 Pinzone JJ, Eng C, Paik J, Brindle KA, Ringel MD, Katz JD. A novelPTEN mutation in Cowden syndrome is associated with a mixed degenerative-erosive arthritic process: Potential molecular pathogenic mechanisms. Am J Med Genet 2007;143A:1522-7. [DOI: 10.1002/ajmg.a.31786] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
491 Rowley PA, Guerrero-Gonzalez J, Alexander AL, Yu JJ. Convergent microstructural brain changes across genetic models of autism spectrum disorder-A pilot study. Psychiatry Res Neuroimaging 2019;283:83-91. [PMID: 30557783 DOI: 10.1016/j.pscychresns.2018.12.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
492 Fink AZ, Gittler JK, Nakrani RN, Alis J, Blumfield E, Levin TL. Imaging findings in systemic childhood diseases presenting with dermatologic manifestations. Clin Imaging 2018;49:17-36. [PMID: 29120812 DOI: 10.1016/j.clinimag.2017.10.015] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
493 Jansen LA, Mirzaa GM, Ishak GE, O'Roak BJ, Hiatt JB, Roden WH, Gunter SA, Christian SL, Collins S, Adams C, Rivière JB, St-Onge J, Ojemann JG, Shendure J, Hevner RF, Dobyns WB. PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia. Brain 2015;138:1613-28. [PMID: 25722288 DOI: 10.1093/brain/awv045] [Cited by in Crossref: 183] [Cited by in F6Publishing: 159] [Article Influence: 30.5] [Reference Citation Analysis]
494 Nishizawa A, Satoh T, Watanabe R, Takayama K, Nakano H, Sawamura D, Yokozeki H. Cowden syndrome: a novel mutation and overlooked glycogenic acanthosis in gingiva. British Journal of Dermatology 2009;160:1116-8. [DOI: 10.1111/j.1365-2133.2009.09072.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
495 Aguissa-touré A, Li G. Genetic alterations of PTEN in human melanoma. Cell Mol Life Sci 2012;69:1475-91. [DOI: 10.1007/s00018-011-0878-0] [Cited by in Crossref: 91] [Cited by in F6Publishing: 85] [Article Influence: 9.1] [Reference Citation Analysis]
496 Shinde SR, Maddika S. PTEN modulates EGFR late endocytic trafficking and degradation by dephosphorylating Rab7. Nat Commun 2016;7:10689. [PMID: 26869029 DOI: 10.1038/ncomms10689] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 15.8] [Reference Citation Analysis]
497 Paparo L, Rossi GB, Delrio P, Rega D, Duraturo F, Liccardo R, Debellis M, Izzo P, De Rosa M. Differential expression of PTEN gene correlates with phenotypic heterogeneity in three cases of patients showing clinical manifestations of PTEN hamartoma tumour syndrome. Hered Cancer Clin Pract 2013;11:8. [PMID: 23886400 DOI: 10.1186/1897-4287-11-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
498 Frazier TW, Embacher R, Tilot AK, Koenig K, Mester J, Eng C. Molecular and phenotypic abnormalities in individuals with germline heterozygous PTEN mutations and autism. Mol Psychiatry. 2015;20:1132-1138. [PMID: 25288137 DOI: 10.1038/mp.2014.125] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 11.9] [Reference Citation Analysis]
499 Haas-Kogan D, Stokoe D. PTEN in brain tumors. Expert Rev Neurother 2008;8:599-610. [PMID: 18416662 DOI: 10.1586/14737175.8.4.599] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
500 Orloff MS, Eng C. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene 2008;27:5387-97. [PMID: 18794875 DOI: 10.1038/onc.2008.237] [Cited by in Crossref: 97] [Cited by in F6Publishing: 79] [Article Influence: 7.5] [Reference Citation Analysis]
501 Charbonnier S, Gallego O, Gavin AC. The social network of a cell: recent advances in interactome mapping. Biotechnol Annu Rev 2008;14:1-28. [PMID: 18606358 DOI: 10.1016/S1387-2656(08)00001-X] [Cited by in Crossref: 69] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
502 Laury AR, Bongiovanni M, Tille J, Kozakewich H, Nosé V. Thyroid Pathology in PTEN -Hamartoma Tumor Syndrome: Characteristic Findings of a Distinct Entity. Thyroid 2011;21:135-44. [DOI: 10.1089/thy.2010.0226] [Cited by in Crossref: 62] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
503 Caux F, Plauchu H, Chibon F, Faivre L, Fain O, Vabres P, Bonnet F, Selma ZB, Laroche L, Gérard M, Longy M. Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity. Eur J Hum Genet 2007;15:767-73. [DOI: 10.1038/sj.ejhg.5201823] [Cited by in Crossref: 86] [Cited by in F6Publishing: 65] [Article Influence: 6.1] [Reference Citation Analysis]
504 Liu YL, Castleberry RP, Emanuel PD. PTEN deficiency is a common defect in juvenile myelomonocytic leukemia. Leuk Res 2009;33:671-7. [PMID: 19010541 DOI: 10.1016/j.leukres.2008.09.036] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]